Louisiana | 72-0395707 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
2001 SE Evangeline Thruway | |
Lafayette, Louisiana | 70508 |
(Address of principal executive offices) | (Zip Code) |
Large accelerated filer: | ☐ | Accelerated filer: ☒ | Smaller reporting company: | ☐ | ||
Non-accelerated filer: | ☐ (Do not check if a smaller reporting company) | Emerging Growth Company: | ☐ |
Class | Outstanding at July 31, 2017 | |
Voting Common Stock | 2,905,757 shares | |
Non-Voting Common Stock | 12,892,321 shares |
Item 1. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 1. | ||
Item 1A. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 5. | ||
Item 6. | ||
June 30, 2017 | December 31, 2016 | |||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash | $ | 2,323 | $ | 2,596 | ||||
Short-term investments | 237,433 | 289,806 | ||||||
Accounts receivable – net | ||||||||
Trade | 133,934 | 128,662 | ||||||
Other | 13,570 | 9,603 | ||||||
Inventories of spare parts – net | 76,155 | 70,402 | ||||||
Prepaid expenses | 13,131 | 9,259 | ||||||
Deferred income taxes | 10,798 | 10,798 | ||||||
Income taxes receivable | 414 | 540 | ||||||
Total current assets | 487,758 | 521,666 | ||||||
Property and equipment – net | 918,134 | 903,977 | ||||||
Restricted cash and investments | 12,396 | 13,038 | ||||||
Other assets | 10,172 | 9,759 | ||||||
Total assets | $ | 1,428,460 | $ | 1,448,440 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | 27,791 | $ | 28,704 | ||||
Accrued and other current liabilities | 33,384 | 28,346 | ||||||
Total current liabilities | 61,175 | 57,050 | ||||||
Long-term debt: | ||||||||
Revolving credit facility | 133,225 | 134,000 | ||||||
Senior Notes issued March 17, 2014, net of debt issuance costs of $2,129 and $2,753, respectively | 497,871 | 497,247 | ||||||
Deferred income taxes | 143,030 | 151,713 | ||||||
Other long-term liabilities | 9,098 | 8,652 | ||||||
Commitments and contingencies (Note 9) | ||||||||
Shareholders’ Equity: | ||||||||
Voting common stock – par value of $0.10; 12,500,000 shares authorized, 2,905,757 shares issued and outstanding | 291 | 291 | ||||||
Non-voting common stock – par value of $0.10; 37,500,000 shares authorized, 12,892,321 and 12,779,646 issued and outstanding at June 30, 2017 and December 31, 2016, respectively | 1,289 | 1,278 | ||||||
Additional paid-in capital | 305,787 | 304,246 | ||||||
Accumulated other comprehensive loss | (254 | ) | (478 | ) | ||||
Retained earnings | 276,948 | 294,441 | ||||||
Total shareholders’ equity | 584,061 | 599,778 | ||||||
Total liabilities and shareholders’ equity | $ | 1,428,460 | $ | 1,448,440 |
Quarter Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Operating revenues, net | $ | 146,424 | $ | 167,136 | $ | 281,042 | $ | 331,152 | ||||||||
Expenses: | ||||||||||||||||
Direct expenses | 126,951 | 152,417 | 263,464 | 304,971 | ||||||||||||
Selling, general and administrative expenses | 14,247 | 11,778 | 27,290 | 23,451 | ||||||||||||
Total operating expenses | 141,198 | 164,195 | 290,754 | 328,422 | ||||||||||||
Loss (gain) on disposal of assets | 7 | (4,298 | ) | 7 | (3,939 | ) | ||||||||||
Equity in loss of unconsolidated affiliates, net | 991 | 76 | 1,994 | 76 | ||||||||||||
Operating income (loss) | 4,228 | 7,163 | (11,713 | ) | 6,593 | |||||||||||
Interest expense | 8,083 | 7,540 | 16,278 | 15,073 | ||||||||||||
Other income – net | (705 | ) | (494 | ) | (1,768 | ) | (1,109 | ) | ||||||||
7,378 | 7,046 | 14,510 | 13,964 | |||||||||||||
(Loss) earnings before income taxes | (3,150 | ) | 117 | (26,223 | ) | (7,371 | ) | |||||||||
Income tax expense (benefit) | 123 | (4,160 | ) | (7,702 | ) | (2,716 | ) | |||||||||
Net (loss) earnings | $ | (3,273 | ) | $ | 4,277 | $ | (18,521 | ) | $ | (4,655 | ) | |||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 15,716 | 15,677 | 15,716 | 15,650 | ||||||||||||
Diluted | 15,716 | 15,718 | 15,716 | 15,650 | ||||||||||||
Net (loss) earnings per share: | ||||||||||||||||
Basic | $ | (0.21 | ) | $ | 0.27 | $ | (1.18 | ) | $ | (0.30 | ) | |||||
Diluted | $ | (0.21 | ) | $ | 0.27 | $ | (1.18 | ) | $ | (0.30 | ) |
Quarter Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Net (loss) earnings | $ | (3,273 | ) | $ | 4,277 | $ | (18,521 | ) | $ | (4,655 | ) | |||||
Unrealized gain on short-term investments | 167 | 210 | 329 | 1,017 | ||||||||||||
Changes in pension plan assets and benefit obligations | 23 | 1 | 22 | 2 | ||||||||||||
Tax effect of the above-listed adjustments | (68 | ) | (75 | ) | (127 | ) | (407 | ) | ||||||||
Total comprehensive (loss) income | $ | (3,151 | ) | $ | 4,413 | $ | (18,297 | ) | $ | (4,043 | ) |
Voting Common Stock | Non-Voting Common Stock | Additional Paid-in Capital | Accumulated Other Com-prehensive (Loss) Income | |||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Retained Earnings | ShareHolders' Equity | |||||||||||||||||||||||||
Balance at December 31, 2015 | 2,906 | $ | 291 | 12,685 | $ | 1,269 | $ | 304,884 | $ | (567 | ) | $ | 321,121 | $ | 626,998 | |||||||||||||||
Net loss | — | — | — | — | — | — | (4,655 | ) | (4,655 | ) | ||||||||||||||||||||
Unrealized gain on short-term investments | — | — | — | — | — | 611 | — | 611 | ||||||||||||||||||||||
Changes in pension plan assets and benefit obligations | — | — | — | — | — | 1 | — | 1 | ||||||||||||||||||||||
Amortization of unearned stock-based compensation | — | — | — | — | 2,882 | — | — | 2,882 | ||||||||||||||||||||||
Issuance of non-voting common stock (upon vesting of restricted stock units) | — | — | 121 | 12 | — | — | — | 12 | ||||||||||||||||||||||
Cancellation of restricted non-voting stock units for tax withholdings on vested shares | — | — | (27 | ) | (3 | ) | (500 | ) | — | — | (503 | ) | ||||||||||||||||||
Retirement of treasury stock | — | — | (8 | ) | — | — | — | — | — | |||||||||||||||||||||
Balance at June 30, 2016 | 2,906 | $ | 291 | 12,771 | $ | 1,278 | $ | 307,266 | $ | 45 | $ | 316,466 | $ | 625,346 | ||||||||||||||||
Voting Common Stock | Non-Voting Common Stock | Additional Paid-in Capital | Accumulated Other Com-prehensive (Loss) Income | |||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Retained Earnings | ShareHolders' Equity | |||||||||||||||||||||||||
Balance at December 31, 2016 | 2,906 | $ | 291 | 12,779 | $ | 1,278 | $ | 304,246 | $ | (478 | ) | $ | 294,441 | $ | 599,778 | |||||||||||||||
Net loss | — | — | — | — | — | — | (18,521 | ) | (18,521 | ) | ||||||||||||||||||||
Unrealized gain on short-term investments | — | — | — | — | — | 210 | — | 210 | ||||||||||||||||||||||
Changes in pension plan assets and benefit obligations | — | — | — | — | — | 14 | — | 14 | ||||||||||||||||||||||
Amortization of unearned stock-based compensation | — | — | — | — | 1,816 | — | — | 1,816 | ||||||||||||||||||||||
Issuance of non-voting common stock (upon vesting of restricted stock units) | — | — | 134 | 13 | — | — | — | 13 | ||||||||||||||||||||||
Cancellation of restricted non-voting stock units for tax withholdings on vested shares | — | — | (21 | ) | (2 | ) | (275 | ) | — | — | (277 | ) | ||||||||||||||||||
Cumulative effect adjustment of unrecognized tax benefits | — | — | — | — | — | — | 1,028 | 1,028 | ||||||||||||||||||||||
Balance at June 30, 2017 | 2,906 | $ | 291 | 12,892 | $ | 1,289 | $ | 305,787 | $ | (254 | ) | $ | 276,948 | $ | 584,061 |
Six Months Ended June 30, | ||||||||
2017 | 2016 | |||||||
Operating activities: | ||||||||
Net loss | $ | (18,521 | ) | $ | (4,655 | ) | ||
Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 34,011 | 34,761 | ||||||
Deferred income taxes | (7,791 | ) | (3,572 | ) | ||||
Loss (gain) on asset dispositions | 7 | (3,939 | ) | |||||
Equity in loss of unconsolidated affiliate, net | 1,994 | 76 | ||||||
Inventory valuation reserves | 2,214 | 2,613 | ||||||
Changes in operating assets and liabilities | (19,863 | ) | (24,485 | ) | ||||
Net cash (used in) provided by operating activities | (7,949 | ) | 799 | |||||
Investing activities: | ||||||||
Purchase of property and equipment | (43,892 | ) | (39,908 | ) | ||||
Proceeds from asset dispositions | 17 | 10,998 | ||||||
Purchase of short-term investments | (134,518 | ) | (151,436 | ) | ||||
Proceeds from sale of short-term investments | 187,217 | 148,838 | ||||||
Payment of deposits on aircraft | (110 | ) | (131 | ) | ||||
Net cash provided by (used in) investing activities | 8,714 | (31,639 | ) | |||||
Financing activities: | ||||||||
Proceeds from line of credit | 66,525 | 150,800 | ||||||
Payments on line of credit | (67,300 | ) | (113,300 | ) | ||||
Repurchase of common stock | (263 | ) | (500 | ) | ||||
Net cash (used in) provided by financing activities | (1,038 | ) | 37,000 | |||||
(Decrease) increase in cash | (273 | ) | 6,160 | |||||
Cash, beginning of period | 2,596 | 2,407 | ||||||
Cash, end of period | $ | 2,323 | $ | 8,567 | ||||
Supplemental Disclosures Cash Flow Information | ||||||||
Cash paid during the period for: | ||||||||
Interest | $ | 15,250 | $ | 14,329 | ||||
Income taxes | $ | 1,131 | $ | 1,879 | ||||
Noncash investing activities: | ||||||||
Other current liabilities and accrued payables related to purchase of property and equipment | $ | 15 | $ | 64 |
Cost Basis | Unrealized Gains | Unrealized Losses | Fair Value | |||||||||||||
(Thousands of dollars) | ||||||||||||||||
Investments: | ||||||||||||||||
Money market mutual funds | $ | 18,079 | $ | — | $ | — | $ | 18,079 | ||||||||
Commercial paper | 17,008 | — | (10 | ) | 16,998 | |||||||||||
U.S. Government agencies | 15,301 | — | (19 | ) | 15,282 | |||||||||||
Corporate bonds and notes | 199,772 | 1 | (318 | ) | 199,455 | |||||||||||
Subtotal | 250,160 | 1 | (347 | ) | 249,814 | |||||||||||
Deferred compensation plan assets included in other assets | 2,562 | — | — | 2,562 | ||||||||||||
Total | $ | 252,722 | $ | 1 | $ | (347 | ) | $ | 252,376 |
Cost Basis | Unrealized Gains | Unrealized Losses | Fair Value | |||||||||||||
(Thousands of dollars) | ||||||||||||||||
Investments: | ||||||||||||||||
Money market mutual funds | $ | 18,118 | $ | — | $ | — | $ | 18,118 | ||||||||
Commercial paper | 27,906 | — | (39 | ) | 27,867 | |||||||||||
U.S. government agencies | 13,295 | — | (32 | ) | 13,263 | |||||||||||
Corporate bonds and notes | 244,202 | 2 | (622 | ) | 243,582 | |||||||||||
Subtotal | 303,521 | 2 | (693 | ) | 302,830 | |||||||||||
Deferred compensation plan assets included in other assets | 2,394 | — | — | 2,394 | ||||||||||||
Total | $ | 305,915 | $ | 2 | $ | (693 | ) | $ | 305,224 |
June 30, 2017 | December 31, 2016 | |||||||||||||||
Amortized Costs | Fair Value | Amortized Costs | Fair Value | |||||||||||||
(Thousands of dollars) | ||||||||||||||||
Due in one year or less | $ | 175,910 | $ | 175,682 | $ | 184,587 | $ | 184,334 | ||||||||
Due within two years | 56,171 | 56,053 | 100,816 | 100,378 | ||||||||||||
Total | $ | 232,081 | $ | 231,735 | $ | 285,403 | $ | 284,712 |
June 30, 2017 | December 31, 2016 | |||||||||
Average Coupon Rate (%) | Average Days To Maturity | Average Coupon Rate (%) | Average Days To Maturity | |||||||
Commercial paper | 0.985 | 83 | 1.001 | 184 | ||||||
U.S. Government agencies | 1.056 | 264 | 0.970 | 400 | ||||||
Corporate bonds and notes | 1.720 | 246 | 1.745 | 318 |
June 30, 2017 | December 31, 2016 | |||||||||||||||
Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | |||||||||||||
(Thousands of dollars) | ||||||||||||||||
Commercial paper | $ | 16,998 | $ | (10 | ) | $ | 27,867 | $ | (39 | ) | ||||||
U.S. Government agencies | 13,287 | (15 | ) | 13,263 | (32 | ) | ||||||||||
Corporate bonds and notes | 172,179 | (286 | ) | 210,836 | (602 | ) | ||||||||||
Total | $ | 202,464 | $ | (311 | ) | $ | 251,966 | $ | (673 | ) |
June 30, 2017 | December 31, 2016 | |||||||||||||||
Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | |||||||||||||
(Thousands of dollars) | ||||||||||||||||
U.S. Government agencies | $ | 1,996 | $ | (4 | ) | $ | — | $ | — | |||||||
Corporate bonds and notes | 19,064 | (32 | ) | 24,196 | (20 | ) | ||||||||||
Total | $ | 21,060 | $ | (36 | ) | $ | 24,196 | $ | (20 | ) |
June 30, 2017 | December 31, 2016 | |||||
Allowance for Contractual Discounts | 56 | % | 56 | % | ||
Allowance for Uncompensated Care | 23 | % | 23 | % |
June 30, 2017 | ||||||||||||
Total | (Level 1) | (Level 2) | ||||||||||
(Thousands of dollars) | ||||||||||||
Investments: | ||||||||||||
Money market mutual funds | $ | 18,079 | $ | 18,079 | $ | — | ||||||
Commercial paper | 16,998 | — | 16,998 | |||||||||
U.S. Government agencies | 15,282 | — | 15,282 | |||||||||
Corporate bonds and notes | 199,455 | — | 199,455 | |||||||||
249,814 | 18,079 | 231,735 | ||||||||||
Deferred compensation plan assets | 2,562 | 2,562 | — | |||||||||
Total | $ | 252,376 | $ | 20,641 | $ | 231,735 | ||||||
December 31, 2016 | ||||||||||||
Total | (Level 1) | (Level 2) | ||||||||||
(Thousands of dollars) | ||||||||||||
Investments: | ||||||||||||
Money market mutual funds | $ | 18,118 | $ | 18,118 | $ | — | ||||||
Commercial paper | 27,867 | — | 27,867 | |||||||||
U.S. government agencies | 13,263 | — | 13,263 | |||||||||
Corporate bonds and notes | 243,582 | — | 243,582 | |||||||||
302,830 | 18,118 | 284,712 | ||||||||||
Deferred compensation plan assets | 2,394 | 2,394 | — | |||||||||
Total | $ | 305,224 | $ | 20,512 | $ | 284,712 |
June 30, 2017 | December 31, 2016 | |||||||||||||||
Principal | Unamortized Debt Issuance Debt Cost | Principal | Unamortized Debt Issuance Debt Cost | |||||||||||||
(Thousands of dollars) | ||||||||||||||||
Senior Notes issued March 17, 2014, interest only payable semi-annually at 5.25%, maturing March 15, 2019 | $ | 500,000 | $ | 2,129 | $ | 500,000 | $ | 2,753 | ||||||||
Revolving Credit Facility due October 1, 2018 with a group of commercial banks, interest payable at variable rates | 133,225 | — | 134,000 | — | ||||||||||||
Total long-term debt | $ | 633,225 | $ | 2,129 | $ | 634,000 | $ | 2,753 |
Quarter Ended June 30, | Six Months Ended June 30, | |||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||
(Thousands of dollars) | ||||||||||||
Weighted average outstanding shares of common stock, basic | 15,716 | 15,677 | 15,716 | 15,650 | ||||||||
Dilutive effect of unvested restricted stock units | — | 41 | — | — | ||||||||
Weighted average outstanding shares of common stock, diluted (1) | 15,716 | 15,718 | 15,716 | 15,650 |
(1) | For the six months ended June 30, 2017, and 2016, 438,812 and 3,180 unvested restricted stock units were excluded from the weighted average outstanding shares of common stock, diluted, respectively as they were anti-dilutive to earnings per share. |
Quarter Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
(Thousands of dollars) | ||||||||||||||||
Stock-based compensation expense: | ||||||||||||||||
Time-based restricted stock units | $ | 556 | $ | 597 | $ | 1,111 | $ | 1,216 | ||||||||
Performance-based restricted stock units | 705 | 809 | 705 | 1,680 | ||||||||||||
Total stock-based compensation expense | $ | 1,261 | $ | 1,406 | $ | 1,816 | $ | 2,896 |
Quarter Ended June 30, | Quarter Ended June 30, | |||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||
Provision for contractual discounts | 63 | % | 65 | % | 66 | % | 69 | % | ||||
Provision for uncompensated care | 10 | % | 7 | % | 7 | % | 4 | % |
Quarter Ended June 30, | Quarter Ended June 30, | |||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||
Insurance | 72 | % | 69 | % | 71 | % | 70 | % | ||||
Medicare | 18 | % | 18 | % | 18 | % | 18 | % | ||||
Medicaid | 8 | % | 9 | % | 9 | % | 10 | % | ||||
Self-Pay | 2 | % | 4 | % | 2 | % | 2 | % |
Quarter Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
(Thousands of dollars) | ||||||||||||||||
Segment operating revenues | ||||||||||||||||
Oil and Gas | $ | 74,668 | $ | 83,185 | $ | 146,399 | $ | 171,622 | ||||||||
Air Medical | 67,222 | 75,547 | 122,559 | 145,607 | ||||||||||||
Technical Services | 4,534 | 8,404 | 12,084 | 13,923 | ||||||||||||
Total operating revenues, net | 146,424 | 167,136 | 281,042 | 331,152 | ||||||||||||
Segment direct expenses (1) | ||||||||||||||||
Oil and Gas (2) | 73,681 | 87,400 | 155,410 | 179,316 | ||||||||||||
Air Medical | 50,402 | 58,997 | 101,243 | 116,041 | ||||||||||||
Technical Services | 3,858 | 6,096 | 8,804 | 9,690 | ||||||||||||
Total segment direct expenses | 127,941 | 152,493 | 265,457 | 305,047 | ||||||||||||
Segment selling, general and administrative expenses | ||||||||||||||||
Oil and Gas | 1,635 | 1,605 | 3,354 | 3,132 | ||||||||||||
Air Medical | 3,263 | 2,642 | 6,144 | 5,237 | ||||||||||||
Technical Services | 356 | 273 | 694 | 497 | ||||||||||||
Total segment selling, general and administrative expenses | 5,254 | 4,520 | 10,192 | 8,866 | ||||||||||||
Total segment expenses | 133,195 | 157,013 | 275,649 | 313,913 | ||||||||||||
Net segment (loss) profit | ||||||||||||||||
Oil and Gas | (648 | ) | (5,820 | ) | (12,365 | ) | (10,826 | ) | ||||||||
Air Medical | 13,557 | 13,908 | 15,172 | 24,329 | ||||||||||||
Technical Services | 320 | 2,035 | 2,586 | 3,736 | ||||||||||||
Total net segment profit | 13,229 | 10,123 | 5,393 | 17,239 | ||||||||||||
Other, net (3) | 697 | 4,792 | 1,761 | 5,048 | ||||||||||||
Unallocated selling, general and administrative costs (1) | (8,993 | ) | (7,258 | ) | (17,099 | ) | (14,585 | ) | ||||||||
Interest expense | (8,083 | ) | (7,540 | ) | (16,278 | ) | (15,073 | ) | ||||||||
(Loss) earnings before income taxes | $ | (3,150 | ) | $ | 117 | $ | (26,223 | ) | $ | (7,371 | ) |
(1) | Included in direct expenses and unallocated selling, general, and administrative costs are the depreciation and amortization expense amounts below: |
Depreciation and Amortization Expense | ||||||||||||||||
Quarter Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
(Thousands of dollars) | ||||||||||||||||
Segment Direct Expense: | ||||||||||||||||
Oil and Gas | $ | 9,824 | $ | 10,024 | $ | 19,686 | $ | 19,942 | ||||||||
Air Medical | 5,219 | 5,132 | 10,696 | 9,387 | ||||||||||||
Technical Services | 148 | 157 | 294 | 285 | ||||||||||||
Total | $ | 15,191 | $ | 15,313 | $ | 30,676 | $ | 29,614 | ||||||||
Unallocated SG&A | $ | 622 | $ | 2,476 | $ | 3,335 | $ | 5,147 |
(2) | Includes Equity in loss of unconsolidated affiliates, net. |
(3) | Consists of gains on disposition of property and equipment and other income. |
June 30, 2017 | ||||||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
ASSETS | ||||||||||||||||||||
Current Assets: | ||||||||||||||||||||
Cash | $ | 48 | $ | 1,328 | $ | 947 | $ | — | $ | 2,323 | ||||||||||
Short-term investments | 237,433 | — | — | — | 237,433 | |||||||||||||||
Accounts receivable – net | 78,334 | 63,020 | 8,969 | (2,819 | ) | 147,504 | ||||||||||||||
Intercompany receivable | — | 105,938 | — | (105,938 | ) | — | ||||||||||||||
Inventories of spare parts – net | 67,148 | 9,007 | — | — | 76,155 | |||||||||||||||
Prepaid expenses | 10,554 | 2,394 | 183 | — | 13,131 | |||||||||||||||
Deferred income taxes | 10,798 | — | — | — | 10,798 | |||||||||||||||
Income taxes receivable | 418 | (4 | ) | — | — | 414 | ||||||||||||||
Total current assets | 404,733 | 181,683 | 10,099 | (108,757 | ) | 487,758 | ||||||||||||||
Investment in subsidiaries | 376,032 | — | — | (376,032 | ) | — | ||||||||||||||
Property and equipment – net | 626,402 | 291,118 | 614 | — | 918,134 | |||||||||||||||
Restricted cash and investments | 12,382 | — | 14 | — | 12,396 | |||||||||||||||
Other assets | 9,168 | 1,004 | — | — | 10,172 | |||||||||||||||
Total assets | $ | 1,428,717 | $ | 473,805 | $ | 10,727 | $ | (484,789 | ) | $ | 1,428,460 | |||||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
Current Liabilities: | ||||||||||||||||||||
Accounts payable | $ | 24,177 | $ | 3,200 | $ | 3,233 | $ | (2,819 | ) | $ | 27,791 | |||||||||
Accrued and other current liabilities | 24,508 | 7,836 | 1,040 | — | 33,384 | |||||||||||||||
Intercompany payable | 97,739 | — | 8,199 | (105,938 | ) | — | ||||||||||||||
Total current liabilities | 146,424 | 11,036 | 12,472 | (108,757 | ) | 61,175 | ||||||||||||||
Long-term debt | 631,096 | — | — | — | 631,096 | |||||||||||||||
Deferred income taxes and other long-term liabilities | 67,136 | 83,926 | 1,066 | — | 152,128 | |||||||||||||||
Shareholders’ Equity: | ||||||||||||||||||||
Common stock and paid-in capital | 307,367 | 77,951 | 1,375 | (79,326 | ) | 307,367 | ||||||||||||||
Accumulated other comprehensive loss | (254 | ) | — | — | — | (254 | ) | |||||||||||||
Retained earnings | 276,948 | 300,892 | (4,186 | ) | (296,706 | ) | 276,948 | |||||||||||||
Total shareholders’ equity | 584,061 | 378,843 | (2,811 | ) | (376,032 | ) | 584,061 | |||||||||||||
Total liabilities and shareholders’ equity | $ | 1,428,717 | $ | 473,805 | $ | 10,727 | $ | (484,789 | ) | $ | 1,428,460 |
December 31, 2016 | ||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries (1) | Eliminations | Consolidated | |||||||||||||
ASSETS | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash | $ | 36 | $ | 2,560 | $ | — | $ | 2,596 | ||||||||
Short-term investments | 289,806 | — | — | 289,806 | ||||||||||||
Accounts receivable – net | 71,458 | 66,807 | — | 138,265 | ||||||||||||
Intercompany receivable | — | 57,904 | (57,904 | ) | — | |||||||||||
Inventories of spare parts – net | 61,834 | 8,568 | — | 70,402 | ||||||||||||
Prepaid expenses | 6,990 | 2,269 | — | 9,259 | ||||||||||||
Deferred income taxes | 10,798 | — | — | 10,798 | ||||||||||||
Income taxes receivable | 558 | (18 | ) | — | 540 | |||||||||||
Total current assets | 441,480 | 138,090 | (57,904 | ) | 521,666 | |||||||||||
Investment in subsidiaries and others | 353,160 | — | (353,160 | ) | — | |||||||||||
Property and equipment – net | 589,104 | 314,873 | — | 903,977 | ||||||||||||
Restricted investments | 13,023 | 15 | — | 13,038 | ||||||||||||
Other assets | 8,660 | 1,099 | — | 9,759 | ||||||||||||
Total assets | $ | 1,405,427 | $ | 454,077 | $ | (411,064 | ) | $ | 1,448,440 | |||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Accounts payable | $ | 22,744 | $ | 5,960 | $ | — | $ | 28,704 | ||||||||
Accrued and other current liabilities | 18,725 | 9,621 | — | 28,346 | ||||||||||||
Intercompany payable | 57,904 | — | (57,904 | ) | — | |||||||||||
Total current liabilities | 99,373 | 15,581 | (57,904 | ) | 57,050 | |||||||||||
Long-term debt | 631,247 | — | — | 631,247 | ||||||||||||
Deferred income taxes and other long-term liabilities | 75,029 | 85,336 | — | 160,365 | ||||||||||||
Shareholders’ Equity: | ||||||||||||||||
Common stock and paid-in capital | 305,815 | 79,191 | (79,191 | ) | 305,815 | |||||||||||
Accumulated other comprehensive loss | (478 | ) | — | — | (478 | ) | ||||||||||
Retained earnings | 294,441 | 273,969 | (273,969 | ) | 294,441 | |||||||||||
Total shareholders’ equity | 599,778 | 353,160 | (353,160 | ) | 599,778 | |||||||||||
Total liabilities and shareholders’ equity | $ | 1,405,427 | $ | 454,077 | $ | (411,064 | ) | $ | 1,448,440 |
(1) | Foreign subsidiaries represent minor subsidiaries and are included in the guarantors’ subsidiaries amounts. |
For the quarter ended June 30, 2017 | ||||||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
Operating revenues, net | $ | 75,045 | $ | 68,857 | $ | 5,341 | $ | (2,819 | ) | $ | 146,424 | |||||||||
Expenses: | ||||||||||||||||||||
Direct expenses | 72,598 | 51,806 | 5,366 | (2,819 | ) | 126,951 | ||||||||||||||
Selling, general and administrative expenses | 10,916 | 3,269 | 66 | (4 | ) | 14,247 | ||||||||||||||
Total operating expenses | 83,514 | 55,075 | 5,432 | (2,823 | ) | 141,198 | ||||||||||||||
Loss (gain) on disposal of assets, net | 8 | (1 | ) | — | — | 7 | ||||||||||||||
Equity in (income) loss of unconsolidated affiliates, net | (75 | ) | — | 1,066 | — | 991 | ||||||||||||||
Operating (loss) income | (8,402 | ) | 13,783 | (1,157 | ) | 4 | 4,228 | |||||||||||||
Equity in net income of consolidated subsidiaries | (14,613 | ) | — | — | 14,613 | — | ||||||||||||||
Interest expense | 8,082 | 1 | — | — | 8,083 | |||||||||||||||
Other income, net | (708 | ) | (1 | ) | — | 4 | (705 | ) | ||||||||||||
(7,239 | ) | — | — | 14,617 | 7,378 | |||||||||||||||
(Loss) earnings before income taxes | (1,163 | ) | 13,783 | (1,157 | ) | (14,613 | ) | (3,150 | ) | |||||||||||
Income tax expense (benefit) | 2,110 | (1,987 | ) | — | — | 123 | ||||||||||||||
Net (loss) earnings | $ | (3,273 | ) | $ | 15,770 | $ | (1,157 | ) | $ | (14,613 | ) | $ | (3,273 | ) |
For the quarter ended June 30, 2016 | ||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries (1) | Eliminations | Consolidated | |||||||||||||
Operating revenues, net | $ | 89,365 | $ | 77,771 | $ | — | $ | 167,136 | ||||||||
Expenses: | ||||||||||||||||
Direct expenses | 89,535 | 62,882 | — | 152,417 | ||||||||||||
Selling, general and administrative expenses | 9,232 | 2,871 | (325 | ) | 11,778 | |||||||||||
Total operating expenses | 98,767 | 65,753 | (325 | ) | 164,195 | |||||||||||
Gain on disposal of assets, net | (4,298 | ) | — | — | (4,298 | ) | ||||||||||
Equity in loss of consolidated affiliates, net | 76 | — | — | 76 | ||||||||||||
Operating (loss) income | (5,180 | ) | 12,018 | 325 | 7,163 | |||||||||||
Equity in net income of consolidated subsidiaries | (7,035 | ) | — | 7,035 | — | |||||||||||
Interest expense | 7,534 | 6 | — | 7,540 | ||||||||||||
Other income, net | (819 | ) | — | 325 | (494 | ) | ||||||||||
(320 | ) | 6 | 7,360 | 7,046 | ||||||||||||
(Loss) earnings before income taxes | (4,860 | ) | 12,012 | (7,035 | ) | 117 | ||||||||||
Income tax (benefit) expense | (9,137 | ) | 4,977 | — | (4,160 | ) | ||||||||||
Net earnings | $ | 4,277 | $ | 7,035 | $ | (7,035 | ) | $ | 4,277 |
(1) | Foreign subsidiaries represent minor subsidiaries and are included in the guarantors’ subsidiaries amounts. |
For the six months ended June 30, 2017 | ||||||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
Operating revenues, net | $ | 149,329 | $ | 126,330 | $ | 8,202 | $ | (2,819 | ) | $ | 281,042 | |||||||||
Expenses: | ||||||||||||||||||||
Direct expenses | 154,942 | 104,187 | 7,154 | (2,819 | ) | 263,464 | ||||||||||||||
Selling, general and administrative expenses | 21,024 | 6,155 | 120 | (9 | ) | 27,290 | ||||||||||||||
Total operating expenses | 175,966 | 110,342 | 7,274 | (2,828 | ) | 290,754 | ||||||||||||||
Loss (gain) on disposal of assets, net | 8 | (1 | ) | — | — | 7 | ||||||||||||||
Equity in loss (income) of unconsolidated affiliates, net | 928 | — | 1,066 | — | 1,994 | |||||||||||||||
Operating income (loss) | (27,573 | ) | 15,989 | (138 | ) | 9 | (11,713 | ) | ||||||||||||
Equity in net income of consolidated subsidiaries | (17,243 | ) | — | — | 17,243 | — | ||||||||||||||
Interest expense | 16,256 | 22 | — | — | 16,278 | |||||||||||||||
Other income, net | (1,776 | ) | (1 | ) | — | 9 | (1,768 | ) | ||||||||||||
(2,763 | ) | 21 | — | 17,252 | 14,510 | |||||||||||||||
(Loss) earnings before income taxes | (24,810 | ) | 15,968 | (138 | ) | (17,243 | ) | (26,223 | ) | |||||||||||
Income tax (benefit) expense | (6,289 | ) | (1,413 | ) | — | — | (7,702 | ) | ||||||||||||
Net (loss) earnings | $ | (18,521 | ) | $ | 17,381 | $ | (138 | ) | $ | (17,243 | ) | $ | (18,521 | ) |
For the six months ended June 30, 2016 | ||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries (1) | Eliminations | Consolidated | |||||||||||||
Operating revenues, net | $ | 181,234 | $ | 149,918 | $ | — | $ | 331,152 | ||||||||
Expenses: | ||||||||||||||||
Direct expenses | 181,572 | 123,399 | — | 304,971 | ||||||||||||
Selling, general and administrative expenses | 18,275 | 5,674 | (498 | ) | 23,451 | |||||||||||
Total operating expenses | 199,847 | 129,073 | (498 | ) | 328,422 | |||||||||||
Gain on disposal of assets, net | (3,939 | ) | — | — | (3,939 | ) | ||||||||||
Equity in loss of unconsolidated affiliate | 76 | — | — | 76 | ||||||||||||
Operating (loss) income | (14,750 | ) | 20,845 | 498 | 6,593 | |||||||||||
Equity in net income of consolidated subsidiaries | (12,090 | ) | — | 12,090 | — | |||||||||||
Interest expense | 15,047 | 26 | — | 15,073 | ||||||||||||
Other income, net | (1,603 | ) | (4 | ) | 498 | (1,109 | ) | |||||||||
1,354 | 22 | 12,588 | 13,964 | |||||||||||||
(Loss) earnings before income taxes | (16,104 | ) | 20,823 | (12,090 | ) | (7,371 | ) | |||||||||
Income tax (benefit) expense | (11,449 | ) | 8,733 | — | (2,716 | ) | ||||||||||
Net (loss) earnings | $ | (4,655 | ) | $ | 12,090 | $ | (12,090 | ) | $ | (4,655 | ) |
(1) | Foreign subsidiaries represent minor subsidiaries and are included in the guarantors’ subsidiaries amounts. |
For the quarter ended June 30, 2017 | ||||||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
Net (loss) earnings | $ | (3,273 | ) | $ | 15,770 | $ | (1,157 | ) | $ | (14,613 | ) | $ | (3,273 | ) | ||||||
Unrealized gain on short-term investments | 167 | — | — | — | 167 | |||||||||||||||
Changes in pension plan asset and benefit obligation | 23 | — | — | — | 23 | |||||||||||||||
Tax effect of the above-listed adjustments | (68 | ) | — | — | — | (68 | ) | |||||||||||||
Total comprehensive (loss) income | $ | (3,151 | ) | $ | 15,770 | $ | (1,157 | ) | $ | (14,613 | ) | $ | (3,151 | ) |
For the quarter ended June 30, 2016 | ||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries (1) | Eliminations | Consolidated | |||||||||||||
Net earnings | $ | 4,277 | $ | 7,035 | $ | (7,035 | ) | $ | 4,277 | |||||||
Unrealized gain on short-term investments | 210 | — | — | 210 | ||||||||||||
Changes in pension plan asset and benefit obligations | 1 | — | — | 1 | ||||||||||||
Tax effect of the above-listed adjustments | (75 | ) | — | — | (75 | ) | ||||||||||
Total comprehensive (loss) income | $ | 4,413 | $ | 7,035 | $ | (7,035 | ) | $ | 4,413 |
(1) | Foreign subsidiaries represent minor subsidiaries and are included in the guarantors’ subsidiaries amounts. |
For the six months ended June 30, 2017 | ||||||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
Net (loss) earnings | $ | (18,521 | ) | $ | 17,381 | $ | (138 | ) | $ | (17,243 | ) | $ | (18,521 | ) | ||||||
Unrealized gain on short-term investments | 329 | — | — | — | 329 | |||||||||||||||
Changes in pension plan asset and benefit obligation | 22 | — | — | — | 22 | |||||||||||||||
Tax effect of the above-listed adjustments | (127 | ) | — | — | — | (127 | ) | |||||||||||||
Total comprehensive (loss) income | $ | (18,297 | ) | $ | 17,381 | $ | (138 | ) | $ | (17,243 | ) | $ | (18,297 | ) |
For the six months ended June 30, 2016 | ||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries (1) | Eliminations | Consolidated | |||||||||||||
Net (loss) earnings | $ | (4,655 | ) | $ | 12,090 | $ | (12,090 | ) | $ | (4,655 | ) | |||||
Unrealized gain on short-term investments | 1,017 | — | — | 1,017 | ||||||||||||
Changes in pension plan asset and benefit obligations | 2 | — | — | 2 | ||||||||||||
Tax effect of the above-listed adjustments | (407 | ) | — | — | (407 | ) | ||||||||||
Total comprehensive (loss) income | $ | (4,043 | ) | $ | 12,090 | $ | (12,090 | ) | $ | (4,043 | ) |
(1) | Foreign subsidiaries represent minor subsidiaries and are included in the guarantors’ subsidiaries amounts. |
For the six months ended June 30, 2017 | ||||||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Eliminations | Consolidated | ||||||||||||||||
Net cash (used in) provided by operating activities | $ | (34,236 | ) | $ | 18,916 | $ | 7,371 | $ | — | $ | (7,949 | ) | ||||||||
Investing activities: | ||||||||||||||||||||
Purchase of property and equipment | (43,892 | ) | — | — | — | (43,892 | ) | |||||||||||||
Proceeds from asset dispositions | 17 | — | — | — | 17 | |||||||||||||||
Purchase of short-term investments | (134,518 | ) | — | — | — | (134,518 | ) | |||||||||||||
Proceeds from sale of short-term investments | 187,217 | — | — | — | 187,217 | |||||||||||||||
Payments of deposits on aircraft | (110 | ) | — | — | — | (110 | ) | |||||||||||||
Net cash provided by (used in) investing activities | 8,714 | — | — | — | 8,714 | |||||||||||||||
Financing activities: | ||||||||||||||||||||
Proceeds from line of credit | 66,525 | — | — | — | 66,525 | |||||||||||||||
Payments on line of credit | (67,300 | ) | — | — | — | (67,300 | ) | |||||||||||||
Repurchase of common stock | (263 | ) | — | — | — | (263 | ) | |||||||||||||
Due to/from affiliate, net | 26,572 | (19,688 | ) | (6,884 | ) | — | — | |||||||||||||
Net cash provided by (used in) financing activities | 25,534 | (19,688 | ) | (6,884 | ) | — | (1,038 | ) | ||||||||||||
Increase (decrease) in cash | 12 | (772 | ) | 487 | — | (273 | ) | |||||||||||||
Cash, beginning of period | 36 | 2,100 | 460 | — | 2,596 | |||||||||||||||
Cash, end of period | $ | 48 | $ | 1,328 | $ | 947 | $ | — | $ | 2,323 |
For the six months ended June 30, 2016 | ||||||||||||||||
Parent Company Only (issuer) | Guarantor Subsidiaries (1) | Eliminations | Consolidated | |||||||||||||
Net cash (used in) provided by operating activities | $ | (12,954 | ) | $ | 13,753 | $ | — | $ | 799 | |||||||
Investing activities: | ||||||||||||||||
Purchase of property and equipment | (39,535 | ) | (373 | ) | — | (39,908 | ) | |||||||||
Proceeds from asset dispositions | 10,998 | — | — | 10,998 | ||||||||||||
Purchase of short-term investments | (151,436 | ) | — | — | (151,436 | ) | ||||||||||
Proceeds from sale of short-term investments | 148,838 | — | — | 148,838 | ||||||||||||
Payments of deposits on aircraft | (131 | ) | — | — | (131 | ) | ||||||||||
Net cash used in investing activities | (31,266 | ) | (373 | ) | — | (31,639 | ) | |||||||||
Financing activities: | ||||||||||||||||
Proceeds from line of credit | 150,800 | — | — | 150,800 | ||||||||||||
Payments on line of credit | (113,300 | ) | — | — | (113,300 | ) | ||||||||||
Repurchase of common stock | (500 | ) | — | — | (500 | ) | ||||||||||
Due to/from affiliate, net | 7,214 | (7,214 | ) | — | — | |||||||||||
Net cash provided by (used in) financing activities | 44,214 | (7,214 | ) | — | 37,000 | |||||||||||
(Decrease) increase in cash | (6 | ) | 6,166 | — | 6,160 | |||||||||||
Cash, beginning of period | 46 | 2,361 | — | 2,407 | ||||||||||||
Cash, end of period | $ | 40 | $ | 8,527 | $ | — | $ | 8,567 |
(1) | Foreign subsidiaries represent minor subsidiaries and are included in the guarantors’ subsidiaries amounts. |
• | The level of offshore oil and gas exploration and production activities in the areas in which we operate, primarily in the Gulf of Mexico. Operating revenues from our Oil and Gas segment relate substantially to operations in the Gulf of Mexico. Many of the helicopters we have purchased recently are larger aircraft intended to service deepwater activities and the margins we earn on these aircraft are generally higher than on smaller aircraft. During periods when the level of offshore activity increases, demand for our offshore flight services typically increases, directly affecting our revenue and profitability. Also, during periods when deepwater offshore activity increases, the demand for our medium and heavy aircraft usually increases, creating a positive impact on revenue and earnings. Conversely, a reduction in offshore oil and gas activities generally, or deepwater offshore activity particularly, typically negatively impacts our aircraft utilization, flight volumes, and overall demand for our aircraft, thereby creating a negative impact on our revenue and earnings. |
• | Patient transports and flight volume in our Air Medical segment. In the independent provider programs under our Air Medical segment, our revenue is directly dependent upon the number and length of patient transports provided in a given period, which is impacted primarily by the number of bases operated by us, competitive factors and weather. The volume of flight utilization of our aircraft by our customers under our traditional provider Air Medical programs also has a direct impact on the amount of revenue earned in a given period, although to a lesser degree than under our independent provider programs. Independent provider programs generated approximately 81%, 74%, 65% and 61% of our Air Medical segment revenues for the six months ended June 30, 2017, and the years ended December 31, 2016, 2015 and 2014, respectively, with the balance of our Air Medical segment revenue attributable to our traditional provider programs. |
• | Payor mix and reimbursement rates in our Air Medical segment. Under our independent provider programs, our revenue recognition, net of allowances, during any particular period is dependent upon the rate at which our various types of customers reimburse us for our Air Medical services, which we refer to as our “payor mix.” Reimbursement rates vary among payor types and typically the reimbursement rate of commercial insurers is higher than Medicare, Medicaid, and self-pay reimbursement rates. Moreover, Medicare and Medicaid reimbursement rates have decreased in recent years and our receipt of payments from these programs is subject to various regulatory and appropriations risks discussed in this and other of our periodic reports filed with the SEC. Changes during any particular period in our payor mix, reimbursement rates, or uncompensated care rates will have a direct impact on our revenues. |
• | Direct expenses. Our business is capital-intensive and highly competitive. Salaries and aircraft maintenance comprise a large portion of our operating expenses. Our aircraft must be maintained to a high standard of quality and undergo periodic and routine maintenance procedures. Higher utilization of our aircraft will result in more frequent maintenance, resulting in higher maintenance costs. In periods of low flight activity, we continue to maintain our aircraft, consequently reducing our margins. In addition, we are also dependent upon pilots, mechanics, and medical crew to operate our business. To attract and retain qualified personnel, we must maintain competitive wages, which places downward pressure on our margins. |
Quarter Ended June 30, | Favorable (Unfavorable) | |||||||||||
2017 | 2016 | |||||||||||
(Thousands of dollars, except flight hours, patient transports, and aircraft) | ||||||||||||
Segment operating revenues | ||||||||||||
Oil and Gas | $ | 74,668 | $ | 83,185 | $ | (8,517 | ) | |||||
Air Medical | 67,222 | 75,547 | (8,325 | ) | ||||||||
Technical Services | 4,534 | 8,404 | (3,870 | ) | ||||||||
Total operating revenues | 146,424 | 167,136 | (20,712 | ) | ||||||||
Segment direct expenses | ||||||||||||
Oil and Gas (1) | 73,681 | 87,400 | 13,719 | |||||||||
Air Medical | 50,402 | 58,997 | 8,595 | |||||||||
Technical Services | 3,858 | 6,096 | 2,238 | |||||||||
Total segment direct expenses | 127,941 | 152,493 | 24,552 | |||||||||
Segment selling, general and administrative expenses | ||||||||||||
Oil and Gas | 1,635 | 1,605 | (30 | ) | ||||||||
Air Medical | 3,263 | 2,642 | (621 | ) | ||||||||
Technical Services | 356 | 273 | (83 | ) | ||||||||
Total segment selling, general and administrative expenses | 5,254 | 4,520 | (734 | ) | ||||||||
Total segment expenses | 133,195 | 157,013 | 23,818 | |||||||||
Net segment (loss) profit | ||||||||||||
Oil and Gas | (648 | ) | (5,820 | ) | 5,172 | |||||||
Air Medical | 13,557 | 13,908 | (351 | ) | ||||||||
Technical Services | 320 | 2,035 | (1,715 | ) | ||||||||
Total net segment profit (2) | 13,229 | 10,123 | 3,106 | |||||||||
Other, net (3) | 697 | 4,792 | (4,095 | ) | ||||||||
Unallocated selling, general and administrative costs (4) | (8,993 | ) | (7,258 | ) | (1,735 | ) | ||||||
Interest expense | (8,083 | ) | (7,540 | ) | (543 | ) | ||||||
(Loss) earnings before income taxes | (3,150 | ) | 117 | (3,267 | ) | |||||||
Income tax expense (benefit) | 123 | (4,160 | ) | (4,283 | ) | |||||||
Net (loss) earnings | $ | (3,273 | ) | $ | 4,277 | $ | (7,550 | ) | ||||
Flight hours: | ||||||||||||
Oil and Gas | 19,683 | 20,724 | (1,041 | ) | ||||||||
Air Medical (5) | 9,652 | 9,519 | 133 | |||||||||
Technical Services | — | 9 | (9 | ) | ||||||||
Total | 29,335 | 30,252 | (917 | ) | ||||||||
Air Medical Transports (6) | 5,121 | 4,823 | 298 |
(1) | Includes Equity in loss of unconsolidated affiliates, net. |
(2) | These financial measures have not been prepared in accordance with generally accepted accounting principles (“GAAP”) and have not been audited or reviewed by our independent registered public accounting firm. These financial measures are therefore considered non-GAAP financial measures. Management believes these non-GAAP financial measures provide meaningful supplemental information regarding our results of operations. A description of the adjustments to and reconciliations of these non-GAAP financial measures to the most comparable GAAP financial measures is as follows: |
Quarter Ended June 30, | ||||||||
2017 | 2016 | |||||||
Total net segment profit | $ | 13,229 | $ | 10,123 | ||||
Other, net | 697 | 4,792 | ||||||
Unallocated selling, general and administrative costs | (8,993 | ) | (7,258 | ) | ||||
Interest expense | (8,083 | ) | (7,540 | ) | ||||
(Loss) earnings before income taxes | $ | (3,150 | ) | $ | 117 |
(3) | Consists of gains on disposition of property and equipment, and other income. |
(4) | Represents corporate overhead expenses not allocable to segments. |
(5) | Flight hours include 2,298 flight hours associated with traditional provider contracts during the second quarter of 2017, compared to 2,452 flight hours in the prior year quarter. |
(6) | Represents individual patient transports for the period. |
Six Months Ended June 30, | Favorable (Unfavorable) | |||||||||||
2017 | 2016 | |||||||||||
(Thousands of dollars, except flight hours, patient transports, and aircraft) | ||||||||||||
Segment operating revenues | ||||||||||||
Oil and Gas | $ | 146,399 | $ | 171,622 | $ | (25,223 | ) | |||||
Air Medical | 122,559 | 145,607 | (23,048 | ) | ||||||||
Technical Services | 12,084 | 13,923 | (1,839 | ) | ||||||||
Total operating revenues | 281,042 | 331,152 | (50,110 | ) | ||||||||
Segment direct expenses | ||||||||||||
Oil and Gas (1) | 155,410 | 179,316 | 23,906 | |||||||||
Air Medical | 101,243 | 116,041 | 14,798 | |||||||||
Technical Services | 8,804 | 9,690 | 886 | |||||||||
Total segment direct expenses | 265,457 | 305,047 | 39,590 | |||||||||
Segment selling, general and administrative expenses | ||||||||||||
Oil and Gas | 3,354 | 3,132 | (222 | ) | ||||||||
Air Medical | 6,144 | 5,237 | (907 | ) | ||||||||
Technical Services | 694 | 497 | (197 | ) | ||||||||
Total segment selling, general and administrative expenses | 10,192 | 8,866 | (1,326 | ) | ||||||||
Total segment expenses | 275,649 | 313,913 | 38,264 | |||||||||
Net segment (loss) profit | ||||||||||||
Oil and Gas | (12,365 | ) | (10,826 | ) | (1,539 | ) | ||||||
Air Medical | 15,172 | 24,329 | (9,157 | ) | ||||||||
Technical Services | 2,586 | 3,736 | (1,150 | ) | ||||||||
Total net segment profit (2) | 5,393 | 17,239 | (11,846 | ) | ||||||||
Other, net (3) | 1,761 | 5,048 | (3,287 | ) | ||||||||
Unallocated selling, general and administrative costs (4) | (17,099 | ) | (14,585 | ) | (2,514 | ) | ||||||
Interest expense | (16,278 | ) | (15,073 | ) | (1,205 | ) | ||||||
Loss before income taxes | (26,223 | ) | (7,371 | ) | (18,852 | ) | ||||||
Income tax benefit | (7,702 | ) | (2,716 | ) | 4,986 | |||||||
Net loss | $ | (18,521 | ) | $ | (4,655 | ) | $ | (13,866 | ) | |||
Flight hours: | ||||||||||||
Oil and Gas | 37,157 | 41,461 | (4,304 | ) | ||||||||
Air Medical (5) | 18,045 | 18,208 | (163 | ) | ||||||||
Technical Services | 511 | 532 | (21 | ) | ||||||||
Total | 55,713 | 60,201 | (4,488 | ) | ||||||||
Air Medical Transports (6) | 9,418 | 9,326 | 92 | |||||||||
Aircraft operated at period end: (7) | ||||||||||||
Oil and Gas | 128 | 145 | ||||||||||
Air Medical (8) | 104 | 105 | ||||||||||
Technical Services | 6 | 6 | ||||||||||
Total | 238 | 256 |
(1) | Includes Equity in loss of unconsolidated affiliates, net. |
(2) | These financial measures have not been prepared in accordance with generally accepted accounting principles (“GAAP”) and have not been audited or reviewed by our independent registered public accounting firm. These financial measures are therefore considered non-GAAP financial measures. Management believes these non-GAAP financial measures provide meaningful supplemental information regarding our results of operations. A description of the adjustments to and reconciliations of these non-GAAP financial measures to the most comparable GAAP financial measures is as follows: |
Six Months Ended June 30, | ||||||||
2017 | 2016 | |||||||
Total net segment profit | $ | 5,393 | $ | 17,239 | ||||
Other, net | 1,761 | 5,048 | ||||||
Unallocated selling, general and administrative costs | (17,099 | ) | (14,585 | ) | ||||
Interest expense | (16,278 | ) | (15,073 | ) | ||||
Loss before income taxes | $ | (26,223 | ) | $ | (7,371 | ) |
(3) | Consists of gains on disposition of property and equipment, and other income. |
(4) | Represents corporate overhead expenses not allocable to segments. |
(5) | Flight hours include 4,594 flight hours associated with traditional provider contracts for the first half of 2017, compared to 4,729 flight hours in the first half of the prior year. |
(6) | Represents individual patient transports for the period. |
(7) | Represents the total number of aircraft available for use, not all of which were deployed in service as of the date indicated. |
(8) | Includes 6 aircraft as of June 30, 2017 that were owned or leased by customers but operated by us. |
Payment Due by Year | ||||||||||||||||||||||||||||
Total | 2017(1) | 2018 | 2019 | 2020 | 2021 | Beyond 2021 | ||||||||||||||||||||||
(Thousands of dollars) | ||||||||||||||||||||||||||||
Aircraft lease obligations | $ | 191,401 | $ | 18,500 | $ | 34,705 | $ | 30,226 | $ | 26,387 | $ | 26,253 | $ | 55,330 | ||||||||||||||
Other lease obligations | 13,788 | 3,144 | 4,129 | 3,088 | 2,189 | 1,181 | 57 | |||||||||||||||||||||
Long-term debt (2) | 633,225 | — | 133,225 | 500,000 | — | — | — | |||||||||||||||||||||
Senior notes interest (2) | 52,500 | 13,125 | 26,250 | 13,125 | — | — | — | |||||||||||||||||||||
$ | 890,914 | $ | 34,769 | $ | 198,309 | $ | 546,439 | $ | 28,576 | $ | 27,434 | $ | 55,387 |
(1) | Payments due during the last six months of 2017 only. |
(2) | “Long-term debt” reflects the principal amount of debt due under our outstanding senior notes and our revolving credit facility, whereas “senior notes interest” reflects interest accrued under our senior notes only. The actual amount of principal and interest paid in all years may differ from the amounts presented above due to the possible future payment or refinancing of outstanding debt or the issuance of new debt. |
Period | Total Number of Shares Purchased | Average Price Paid per Share | |||||
April 1, 2017 – June 30, 2017 | 12,151 | $ | 10.28 |
3.1 | (i) | Amended and Restated Articles of Incorporation of the Company (incorporated by reference to Exhibit 3(i) to PHI’s Report on Form 10-Q for the quarterly period ended March 31, 2017, filed May 9, 2017). | ||
(ii) | Amended and Restated By-laws of the Company (incorporated by reference to Exhibit 3(ii) to PHI’s Report on Form 10-Q for the quarterly period ended September 30, 2015, filed November 6, 2015). | |||
4.1 | Second Amended and Restated Loan Agreement dated as of September 18, 2013, by and among PHI, Inc., PHI Air Medical, L.L.C, successor to Air Evac Services, Inc., PHI Tech Services, Inc. (formerly Evangeline Airmotive, Inc.), International Helicopter Transport, Inc. and Whitney National Bank (incorporated by reference to Exhibit 4.1 to PHI’s Report on Form 10-Q for the quarterly period ended September 30, 2013, filed on November 8, 2013). | |||
4.2 | First Amendment to Second Amended and Restated Loan Agreement, dated as of March 5, 2014, by and among PHI, Inc., PHI Air Medical, L.L.C., PHI Tech Services, Inc., International Helicopter Transport, Inc. and Whitney National Bank (incorporated by reference to Exhibit 4.1 to PHI’s Report on Form 8-K filed March 6, 2014). | |||
4.3 | Second Amendment to Second Amended and Restated Loan Agreement, dated as of September 26, 2014, by and among PHI, Inc., PHI Air Medical, L.L.C., PHI Tech Services, Inc., International Helicopter Transport, Inc. and Whitney National Bank (incorporated by reference to Exhibit 4.3 to PHI’s Report on Form 10-Q for the quarterly period ended September 30, 2014, filed November 7, 2014). | |||
4.4 | Third Amendment to Second Amended and Restated Loan Agreement, dated as of September 25, 2015, by and among PHI, Inc., PHI Air Medical, L.L.C., PHI Tech Services, Inc., International Helicopter Transport, Inc. and Whitney National Bank (incorporated by reference to Exhibit 4.4 to PHI’s Report on Form 10-Q for the quarterly period ended September 30, 2015, filed November 6, 2015). | |||
4.5 | Fourth Amendment to Second Amended and Restated Loan Agreement, dated as of September 30, 2016, by and among PHI, Inc., PHI Air Medical, L.L.C., PHI Tech Services, Inc., International Helicopter Transport, Inc. and Whitney National Bank. (incorporated by reference to Exhibit 4.5 to PHI’s Report on Form 10-Q for the quarterly period ended September 30, 2016, filed November 7, 2016). | |||
4.6 | Indenture, dated as of March 17, 2014, by and among PHI, Inc., the subsidiary guarantors and U.S. Bank National Association, relating to the issuance by PHI, Inc. of its 5.25% Senior Notes due 2019 (incorporated by reference to Exhibit 4.2 to PHI’s Report on Form 8-K filed March 17, 2014). | |||
4.7 | Form of 5.25% Senior Note due 2019 (incorporated by reference to Exhibit 4.2 to PHI’s Report on Form 8-K filed on March 6, 2014). | |||
10.1† | Second Amended and Restated PHI Inc. Long-Term Incentive Plan (incorporated by reference to Appendix A to PHI’s Information Statement on Schedule 14C filed April 12, 2017). |
31.1* | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Al A. Gonsoulin, Chairman and Chief Executive Officer. | |
31.2* | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Trudy P. McConnaughhay, Chief Financial Officer. | |
32.1* | Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Al A. Gonsoulin, Chairman and Chief Executive Officer. | |
32.2* | Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Trudy P. McConnaughhay, Chief Financial Officer. | |
101.INS* | XBRL Instance Document | |
101.SCH* | XBRL Taxonomy Extension Schema | |
101.CAL* | XBRL Taxonomy Extension Calculation Linkbase | |
101.DEF* | XBRL Taxonomy Extension Definition Linkbase | |
101.LAB* | XBRL Taxonomy Extension Label Linkbase | |
101.PRE* | XBRL Taxonomy Extension Presentation Linkbase |
PHI, Inc. | ||
August 4, 2017 | By: | /s/ Al A. Gonsoulin |
Al A. Gonsoulin | ||
Chairman and Chief Executive Officer | ||
August 4, 2017 | By: | /s/ Trudy P. McConnaughhay |
Trudy P. McConnaughhay | ||
Chief Financial Officer |
1. | I have reviewed this quarterly report on Form 10-Q of PHI, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
1. | I have reviewed this quarterly report on Form 10-Q of PHI, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
1. | the Quarterly Report on Form 10-Q for the period ended June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
1. | the Quarterly Report on Form 10-Q for the period ended June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Document and Entity Information - shares |
6 Months Ended | |
---|---|---|
Jun. 30, 2017 |
Jul. 31, 2017 |
|
Document Information [Line Items] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Jun. 30, 2017 | |
Document Fiscal Year Focus | 2017 | |
Document Fiscal Period Focus | Q2 | |
Trading Symbol | PHII | |
Entity Registrant Name | PHI INC | |
Entity Central Index Key | 0000350403 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Accelerated Filer | |
Voting Common Stock [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 2,905,757 | |
Non-Voting Common Stock [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 12,892,321 |
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands |
Jun. 30, 2017 |
Dec. 31, 2016 |
---|---|---|
Debt issuance costs | $ 2,129 | $ 2,753 |
Voting Common Stock [Member] | ||
Common stock, par value (in USD per share) | $ 0.10 | $ 0.10 |
Common stock, shares authorized (shares) | 12,500,000 | 12,500,000 |
Common stock, shares issued (shares) | 2,905,757 | 2,905,757 |
Common stock, shares outstanding (shares) | 2,905,757 | 2,905,757 |
Non-Voting Common Stock [Member] | ||
Common stock, par value (in USD per share) | $ 0.10 | $ 0.10 |
Common stock, shares authorized (shares) | 37,500,000 | 37,500,000 |
Common stock, shares issued (shares) | 12,892,321 | 12,779,646 |
Common stock, shares outstanding (shares) | 12,892,321 | 12,779,646 |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
Income Statement [Abstract] | ||||
Operating revenues, net | $ 146,424 | $ 167,136 | $ 281,042 | $ 331,152 |
Expenses: | ||||
Direct expenses | 126,951 | 152,417 | 263,464 | 304,971 |
Selling, general and administrative expenses | 14,247 | 11,778 | 27,290 | 23,451 |
Total operating expenses | 141,198 | 164,195 | 290,754 | 328,422 |
Loss (gain) on disposal of assets | 7 | (4,298) | 7 | (3,939) |
Equity in loss of unconsolidated affiliates, net | 991 | 76 | 1,994 | 76 |
Operating income (loss) | 4,228 | 7,163 | (11,713) | 6,593 |
Interest expense | 8,083 | 7,540 | 16,278 | 15,073 |
Other income – net | (705) | (494) | (1,768) | (1,109) |
Total expenses | 7,378 | 7,046 | 14,510 | 13,964 |
(Loss) earnings before income taxes | (3,150) | 117 | (26,223) | (7,371) |
Income tax expense (benefit) | 123 | (4,160) | (7,702) | (2,716) |
Net (loss) earnings | $ (3,273) | $ 4,277 | $ (18,521) | $ (4,655) |
Weighted average shares outstanding: | ||||
Basic (shares) | 15,716 | 15,677 | 15,716 | 15,650 |
Diluted (shares) | 15,716 | 15,718 | 15,716 | 15,650 |
Net (loss) earnings per share: | ||||
Basic (in USD per share) | $ (0.21) | $ 0.27 | $ (1.18) | $ (0.30) |
Diluted (in USD per share) | $ (0.21) | $ 0.27 | $ (1.18) | $ (0.30) |
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
Statement of Comprehensive Income [Abstract] | ||||
Net (loss) earnings | $ (3,273) | $ 4,277 | $ (18,521) | $ (4,655) |
Unrealized gain on short-term investments | 167 | 210 | 329 | 1,017 |
Changes in pension plan assets and benefit obligations | 23 | 1 | 22 | 2 |
Tax effect of the above-listed adjustments | (68) | (75) | (127) | (407) |
Total comprehensive (loss) income | $ (3,151) | $ 4,413 | $ (18,297) | $ (4,043) |
Basis of Presentation |
6 Months Ended |
---|---|
Jun. 30, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements include the accounts of PHI, Inc. and its subsidiaries (“PHI” or the “Company” or “we” or “our”). In the opinion of management, these condensed consolidated financial statements reflect all adjustments, consisting of only normal, recurring adjustments, necessary to present fairly the financial results for the interim periods presented. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the accompanying notes contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. Our financial results, particularly as they relate to our Oil and Gas segment, are influenced by seasonal fluctuations as discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. For this and other reasons, the results of operations for interim periods are not necessarily indicative of the operating results that may be expected for a full fiscal year. Recently Adopted Accounting Pronouncements - Effective January 1, 2017, we adopted Accounting Standards Update (“ASU”) 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which was issued by the Financial Accounting Standards Board (“FASB”) in March 2016. This new standard requires that excess tax benefits and deficiencies resulting from stock-based compensation awards vesting and exercises be recognized in the income statement. Previously, these amounts were recognized in additional paid-in capital. As a result, during the first quarter of 2017 we recorded a cumulative-effect adjustment of $1.0 million increasing retained earnings and decreasing deferred tax liability on our balance sheet dated June 30, 2017. Accordingly, we recorded income tax expense of $1.5 million in our consolidated statement of income for the six months ended June 30, 2017, in recognition of excess tax deficiencies related to equity compensation. Under this new standard, the corresponding cash flows are now reflected in cash provided by operating activities instead of financing activities, as was previously required. ASU 2016-09 also allows an employer with a statutory income tax withholding obligation to withhold shares with a fair value up to the amount of tax owed using the maximum statutory tax rate in the employee’s applicable jurisdiction. We have elected to continue to withhold the minimum statutory withholding obligation for outstanding awards. We have also elected to continue to estimate equity award forfeitures expected to occur to determine the amount of compensation cost to be recognized in each period. New Accounting Pronouncements - In May 2014, the FASB issued Accounting Standards Update ASU 2014-09, Revenue from Contracts with Customers, which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. Entities can transition to the standard either retrospectively or as a cumulative effect adjustment as of the date of adoption. The new standard is effective for the Company beginning on January 1, 2018. Revenues from our Oil and Gas segment and Air Medical segment hospital contracts are primarily comprised of a fixed monthly fee for a particular model of aircraft, plus a variable component based on flight time. Under the independent provider programs of our Air Medical segment, our revenues are based on a flat rate plus a variable charge per patient-loaded mile, and are recorded net of contractual allowances. We also generate revenue on a cost-plus basis in our Technical Services segment. Based on our initial assessment, the Company does not expect the adoption of this ASU to have a material impact on its condensed consolidated financial statements. Remaining implementation matters include establishing new policies, procedures, and controls and quantifying any adoption date adjustments. The Company will adopt this standard on January 1, 2018 utilizing the modified retrospective method. In February 2016, the FASB issued ASU 2016-02, Leases, which replaces the existing guidance on leasing transactions in ASC 840 to require recognition of the assets and liabilities for the rights and obligations created by those leases on the balance sheet. We are currently evaluating the effects of this standard, and expect the adoption of this standard will result in a material change to our consolidated assets and liabilities based on our lease portfolio as of June 30, 2017. We plan to adopt this standard no later than January 1, 2019. In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory, which will require an entity to recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for annual periods beginning after December 15, 2017, including interim periods within those annual periods. The effects of this standard on our financial position, results of operations, and cash flows are not yet known. We plan to adopt this standard beginning January 1, 2018. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. ASU 2017-01 clarifies the definition of a business and requires that an entity apply certain criteria in order to determine when a set of assets and activities qualifies as a business. The adoption of this standard is expected to result in fewer acquisitions of properties qualifying as acquisitions of businesses and, accordingly, acquisition costs for those acquisitions that do not qualify as businesses will be capitalized rather than expensed. This standard is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years, and should be applied on a prospective basis. Early adoption is permitted. The effects of this standard on our financial position, results of operations, and cash flows are not yet known. We plan to adopt this standard beginning January 1, 2018. In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 simplifies the current two-step goodwill impairment test by eliminating the second step of the test. The new standard requires a one-step impairment test in which an entity compares the fair value of a reporting unit with its carrying amount and recognizes an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, if any. This standard is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and should be applied on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. We do not expect this ASU to have a material impact on our consolidated financial statements. |
Investments |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments | INVESTMENTS We classify all of our short-term investments as available-for-sale. We carry these at fair value and report unrealized gains and losses, net of taxes, in Accumulated other comprehensive loss, which is a separate component of shareholders’ equity in our Condensed Consolidated Balance Sheets. These unrealized gains and losses are also reflected in our Condensed Consolidated Statements of Comprehensive Income and Condensed Consolidated Statements of Shareholders’ Equity. We determine cost, gains, and losses using the specific identification method. Investments consisted of the following as of June 30, 2017:
Investments consisted of the following as of December 31, 2016:
At June 30, 2017 and December 31, 2016, we classified $12.4 million and $13.0 million respectively, of our aggregate investments as long-term investments and recorded them in our Condensed Consolidated Balance Sheets as Restricted cash and investments, as they are securing outstanding letters of credit with maturities beyond one year and a bond relating to foreign operations. The following table presents the cost and fair value of our debt investments based on maturities as of:
The following table presents the average coupon rate percentage and the average days to maturity of our debt investments as of:
The following table presents the fair value and unrealized losses related to our investments that have been in a continuous unrealized loss position for less than twelve months as of:
The following table presents the fair value and unrealized losses related to our investments that have been in a continuous unrealized loss position for more than twelve months as of:
From time to time over the periods covered in our financial statements included herein (and as illustrated in the foregoing tables), our investments have experienced net unrealized losses. We consider these declines in market value to be due to customary market fluctuations, and we do not plan to sell these investments prior to maturity. For these reasons, we do not consider any of our investments to be other than temporarily impaired at June 30, 2017 or December 31, 2016. We have also determined that we did not have any other than temporary impairments relating to credit losses on debt securities for the quarter ended June 30, 2017. For additional information regarding our criteria for making these assessments, see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016. |
Revenue Recognition and Valuation Accounts |
6 Months Ended | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | ||||||||||||||||||||||||||||||||||||
Revenue Recognition And Valuation Accounts [Abstract] | ||||||||||||||||||||||||||||||||||||
Revenue Recognition and Valuation Accounts | REVENUE RECOGNITION AND VALUATION ACCOUNTS We establish the amount of our allowance for doubtful accounts based upon factors relating to the credit risk of specific customers, current market conditions, and other information. Our allowance for doubtful accounts was approximately $6.0 million at June 30, 2017, and December 31, 2016. Revenues related to flights generated by our Air Medical segment are recorded net of contractual allowances under agreements with third party payors and estimated uncompensated care when the services are provided. The allowance for contractual discounts was $110.9 million and $111.9 million as of June 30, 2017 and December 31, 2016, respectively. The allowance for uncompensated care was $46.2 million and $46.3 million as of June 30, 2017 and December 31, 2016, respectively. Included in the allowance for uncompensated care listed above is the value of services to patients who are unable to pay when it is determined that they qualify for charity care. The value of these services was $2.0 million and $2.2 million for the quarters ended June 30, 2017 and 2016, respectively. The value of these services was $4.4 million and $4.7 million for the six months ended June 30, 2017 and 2016, respectively. The estimated cost of providing charity services was $0.4 million for the quarter ended June 30, 2017 and $0.5 million for the quarter ended June 30, 2016. The estimated cost of providing charity services was $1.0 million and $1.2 million for the six months ended June 30, 2017 and 2016, respectively. The estimated costs of providing charity services are based on a calculation that applies a ratio of costs to the charges for uncompensated charity care. The ratio of costs to charges is based on our Air Medical segment’s total expenses divided by gross patient service revenue. The allowance for contractual discounts and estimated uncompensated care (expressed as a percentage of gross segment accounts receivable) as of the dates listed below was as follows:
Under a three-year contract that commenced on September 29, 2012, our Air Medical affiliate provided multiple services to a customer in the Middle East, including helicopter leasing, emergency medical helicopter flight services, aircraft maintenance, provision of spare parts, insurance coverage for the customer-owned aircraft, training services, and base construction. Each of the major services mentioned above qualified as separate units of accounting under the accounting guidance for such arrangements. The selling price for each specific service was determined based upon third-party evidence and estimates. As discussed in greater detail in our Form 10-K for year ended December 2016, this contract, after being extended one year, lapsed on September 30, 2016. We have also established valuation reserves related to obsolete and slow-moving spare parts inventory. The inventory valuation reserves were $17.7 million and $17.3 million at June 30, 2017 and December 31, 2016, respectively. |
Fair Value Measurements |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements | FAIR VALUE MEASUREMENTS Accounting standards require that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs that are not corroborated by market data. The following table summarizes the valuation of our investments and financial instruments by the above pricing levels as of the valuation dates listed:
We hold our short-term investments in an investment fund consisting of high quality money market instruments of governmental and private issuers, which is classified as a short-term investment. Level 1 inputs are quoted prices (unadjusted) for identical assets or liabilities in active markets. These items are traded with sufficient frequency and volume to provide pricing on an ongoing basis. The fair values of the investments in these funds are based on observable market prices, and therefore, have been categorized in Level 1 in the fair value hierarchy. Level 2 inputs reflect quoted prices for identical assets or liabilities that are not actively traded. These items may not be traded daily; examples include commercial paper, corporate bonds and U.S. government agencies debt. There have been no reclassifications of assets between Level 1 and Level 2 investments during the periods covered by the financial statements included in this report. We hold no Level 3 investments. Investments reflected on our balance sheets as Other assets, which we hold to fund liabilities under our Officers’ Deferred Compensation Plan, consist mainly of multiple investment funds that are highly liquid and diversified. Cash, accounts receivable, accounts payable and accrued liabilities, and our revolving credit facility debt all had fair values approximating their carrying amounts at June 30, 2017 and December 31, 2016. Our determination of the estimated fair value of our 5.25% Senior Notes due 2019 and our revolving credit facility debt is derived using Level 2 inputs, including quoted market indications of similar publicly-traded debt. The fair value of our 5.25% Senior Notes due 2019, based on quoted market prices, was $463.0 million and $474.4 million at June 30, 2017 and December 31, 2016, respectively. |
Long Term Debt |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long Term Debt | LONG-TERM DEBT The components of long-term debt as of the dates indicated below were as follows:
Our 5.25% Senior Notes (the “2019 Notes”) will mature on March 15, 2019, are unconditionally guaranteed on a senior basis by each of PHI, Inc’s wholly-owned domestic subsidiaries, and are the general, unsecured obligations of PHI, Inc. and the guarantors. Interest is payable semi-annually on March 15 and September 15 of each year. PHI has the option to redeem some or all of the 2019 Notes at any time on or after March 15, 2016 at specified redemption prices. The indenture governing the 2019 Notes (the “2019 Indenture”) contains, among other things, certain restrictive covenants, including limitations on incurring indebtedness, creating liens, selling assets and entering into certain transactions with affiliates. The covenants also limit PHI’s ability to, among other things, pay cash dividends on common stock, repurchase or redeem common or preferred equity, prepay subordinated debt and make certain investments. Upon the occurrence of a “Change in Control Repurchase Event” (as defined in the 2019 Indenture), PHI will be required, unless it has previously elected to redeem the 2019 Notes as described above, to make an offer to purchase the 2019 Notes for a cash price equal to 101% of their principal amount. Revolving Credit Facility – We have an amended and restated revolving credit facility (our “credit facility”) that matures on October 1, 2018. Under this facility, we can borrow up to $150.0 million at floating interest rates based on either the London Interbank Offered Rate plus 225 basis points or the prime rate (each as defined in our credit facility), at our option. Our credit facility includes usual and customary covenants and events of default for credit facilities of its type. Our ability to borrow under the credit facility is conditioned upon our continued compliance with such covenants, including, among others, (i) covenants that restrict our ability to engage in certain asset sales, mergers or other fundamental changes, to incur liens or to engage in certain other transactions or activities and (ii) financial covenants that stipulate that PHI will maintain a consolidated working capital ratio of at least 2 to 1, a net funded debt to consolidated net worth ratio not greater than 1.5 to 1, a fixed charge coverage ratio of at least 1.1 to 1 if our short term investments fall below $150.0 million, and consolidated net worth of at least $450.0 million (with all such terms or amounts as defined in or determined under our credit facility). As of June 30, 2017, we believe we were in compliance with these covenants. Cash paid to fund interest expense was $1.2 million for the quarter ended June 30, 2017 and $0.6 million for the quarter ended June 30, 2016. Cash paid to fund interest expense was $15.3 million for the six months ended June 30, 2017 and $14.3 million for the six months ended June 30, 2016. Letter of Credit Facility - We maintain a separate letter of credit facility that had $12.4 million and $13.0 million in letters of credit outstanding at June 30, 2017 and December 31, 2016 respectively. We have letters of credit securing our workers compensation policies, a traditional provider contract, and a bond relating to foreign operations. We also have outstanding a letter of credit for $7.6 million issued under our $150.0 million credit facility that reduces the amount we can borrow under that facility. The letter of credit was issued to guaranty our performance under an international contract that was awarded in late 2016. Other - PHI, Inc. has cash management arrangements with certain of its principal subsidiaries, in which substantial portions of the subsidiaries’ cash is regularly advanced to PHI, Inc. Although PHI, Inc. periodically repays these advances to fund the subsidiaries’ cash requirements throughout the year, at any given point in time PHI, Inc. may owe a substantial sum to its subsidiaries under these advances, which, in accordance with generally accepted accounting principles, are eliminated in consolidation and therefore not recognized on our consolidated balance sheets. For additional information, see Note 13. |
Earnings Per Share |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | EARNINGS PER SHARE The components of basic and diluted earnings per share for the quarter and six months ended June 30, 2017 and 2016 are as follows:
|
Stock-Based Compensation |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation | STOCK-BASED COMPENSATION We recognize the cost of employee compensation received in the form of equity instruments based on the grant date fair value of those awards. The table below sets forth the total amount of stock-based compensation expense for the six months and quarter ended June 30, 2017 and 2016.
During the quarter and six months ended June 30, 2017, 417,266 and 447,477 time-based restricted units, respectively, were awarded to managerial employees and 365,539 performance-based restricted units were awarded to managerial employees. During the quarter and six months ended June 30, 2016, 14,288 time-based restricted units were awarded to managerial employees and 5,102 and 308,163 performance-based restricted units were awarded to managerial employees, respectively. |
Asset Disposals |
6 Months Ended |
---|---|
Jun. 30, 2017 | |
Property, Plant and Equipment [Abstract] | |
Asset Disposals | ASSET DISPOSALS There were no sales or disposals of aircraft during the first quarter of 2017. During the second quarter of 2017, we disposed five medium aircraft and related parts inventory utilized in the Oil and Gas segment. These aircraft no longer met our strategic needs. During the first quarter of 2016, we sold one light aircraft previously utilized in the Oil and Gas segment. Cash proceeds totaled $0.9 million, resulting in the loss on the sale of this asset of $0.4 million. During the second quarter of 2016, we sold four light and three medium aircraft and related parts inventory utilized in the Oil and Gas segment. Cash proceeds totaled $10.1 million, resulting in a gain on the sale of these assets of $4.3 million. These aircraft no longer met our strategic needs. |
Commitments and Contingencies |
6 Months Ended |
---|---|
Jun. 30, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | COMMITMENTS AND CONTINGENCIES Commitments – We currently have no aircraft purchase commitments. Total aircraft deposits of $0.5 million were included in Other Assets as of June 30, 2017. This amount represents a deposit on a future lease buyout option. In the event we do not exercise the buyout option, the deposit will be applied against lease payments. As of June 30, 2017, we had options to purchase aircraft under leases, with such purchase options becoming exercisable in 2017 through 2020. The aggregate option purchase prices are $18.5 million in 2017, $127.0 million in 2018, $129.0 million in 2019, and $22.7 million in 2020. In the second quarter of 2017, we purchased one heavy aircraft from a lessor for $17.0 million. Under current conditions, we believe it is unlikely that we will exercise the remaining 2017 purchase options, unless opportunistic conditions arise. Environmental Matters – PHI has recorded an estimated liability of $0.15 million as of June 30, 2017 for environmental response costs. Previously, PHI conducted environmental surveys of its former Lafayette Facility located at the Lafayette Regional Airport, which we vacated in 2001, PHI has determined that limited soil and groundwater contamination exist at two parcels of land at the former facility. An Assessment Report for both parcels was submitted in 2003 (and updated in 2006) to the Louisiana Department of Environmental Quality (LDEQ) and the Louisiana Department of Natural Resources (LDNR). Approvals for the Assessment Report were received from the LDEQ and LDNR in 2010 and 2011, respectively. Since that time, PHI has performed groundwater sampling of the required groundwater monitor well installations at both parcels and submitted these sampling reports to the LDEQ. Pursuant to an agreement with the LDEQ, PHI provided groundwater sample results semi-annually to the LDEQ for both parcels from 2005 to 2015. LDEQ approved a reduction in the sampling program from semi-annual to annual groundwater monitoring in 2015. Based on PHI’s working relationship and agreements with the LDEQ, and the results of ongoing former facility parcel monitoring, PHI believes that ultimate remediation costs for the subject parcels will not be material to PHI’s consolidated financial position, operations or cash flows. Legal Matters – From time to time, we are involved in various legal actions incidental to our business, including actions relating to employee claims, medical malpractice claims, tax issues, grievance hearings before labor regulatory agencies, and miscellaneous third party tort actions. The outcome of these proceedings is not predictable. However, based on current circumstances, we do not believe that the ultimate resolution of our presently pending proceedings, after considering available defenses and any insurance coverage or indemnification rights, will have a material adverse effect on our financial position, results of operations or cash flows. Operating Leases – We lease certain aircraft, facilities, and equipment used in our operations. The related lease agreements, which include both non-cancelable and month-to-month terms, generally provide for fixed monthly rentals, and certain real estate leases also include renewal options. We generally pay all insurance, taxes, and maintenance expenses associated with these leases. All aircraft leases contain purchase options exercisable by us at certain dates in the lease agreements. At June 30, 2017, we had approximately $205.2 million in aggregate commitments under operating leases of which approximately $21.6 million is payable through the second half of 2017. The total lease commitments include $191.4 million for aircraft and $13.8 million for facility lease commitments. |
Segment Information |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information | SEGMENT INFORMATION PHI is primarily a provider of helicopter transport services, including helicopter maintenance and repair services. We report our financial results through the three reportable segments further described below. A segment’s operating profit or loss is its operating revenues less its direct expenses and selling, general and administrative expenses. A portion of our total selling, general and administrative expenses is charged directly to each segment, and a small portion is allocated to that segment. Direct charges represent the vast majority of segment selling, general and administrative expenses. Allocated selling, general and administrative expenses are based primarily on total segment costs as a percentage of total operating costs. Oil and Gas Segment - Our Oil and Gas segment, headquartered in Lafayette, Louisiana, provides helicopter services primarily for the major integrated and independent oil and gas production companies transporting personnel or equipment to offshore platforms in the Gulf of Mexico. Our customers include Shell Oil Company, BP America Production Company, ExxonMobil Production Company, and ConocoPhillips Company, with whom we have worked for 30 or more years, and ENI Petroleum, with whom we have worked for more than 15 years. At June 30, 2017, we had available for use 128 aircraft in this segment. Operating revenue from our Oil and Gas segment is derived mainly from contracts that include a fixed monthly rate for a particular model of aircraft, plus a variable payments based on the amount of flight time. Operating costs for the Oil and Gas segment are primarily aircraft operation costs, including costs for pilots and maintenance personnel. We typically operate under fixed-term contracts with our customers, a substantial portion of which are competitively bid. Our fixed-term contracts have terms of one to seven years (subject to provisions permitting early termination by the customers), with payment in U.S. dollars. For the quarters ended June 30, 2017 and 2016, respectively, approximately 51% and 52% of our total operating revenues were generated by our Oil and Gas segment, with approximately 88% and 92% of these revenues from fixed-term customer contracts. For the six months ended June 30, 2017 and 2016, respectively, approximately 52% of our total operating revenues were generated by our Oil and Gas segment, with approximately 88% and 92% of these revenues from fixed-term customer contracts. The remaining 12% and 8% of these revenues were attributable to work in the spot market and ad hoc flights for contracted customers. Air Medical Segment - The operations of our Air Medical segment are headquartered in Phoenix, Arizona, where we maintain significant separate facilities and administrative staff dedicated to this segment. We provide Air Medical transportation services for hospitals and emergency service agencies throughout the U.S. As of June 30, 2017, our Air Medical segment operated approximately 104 aircraft in 18 states at 72 separate locations. Our Air Medical segment operates primarily under the independent provider model and, to a lesser extent, under the traditional provider model. Under the independent provider model, we have no fixed revenue stream and compete for transport referrals on a daily basis with other independent operators in the area. Under the traditional provider model, we contract directly with the customer to provide their transportation services, with the contracts typically awarded or renewed through competitive bidding. For the quarter ended June 30, 2017 and 2016, approximately 46% and 45% of our total operating revenues were generated by our Air Medical segment, respectively. For the six months ended June 30, 2017 and 2016, approximately 44% of our total operating revenues were generated by our Air Medical segment. As an independent provider, we bill for our services on the basis of a flat rate plus a variable charge per patient-loaded mile, regardless of aircraft model, and are typically compensated by private insurance, Medicaid or Medicare, or directly by transported patients who self-pay. As further described in Note 3, revenues are recorded net of contractual allowances under agreements with third party payors and estimated uncompensated care at the time the services are provided. Contractual allowances and uncompensated care are estimated based on historical collection experience by payor category (consisting mainly of insurance, Medicaid, Medicare, and self-pay). Estimates regarding the payor mix and changes in reimbursement rates are the factors most subject to sensitivity and variability in calculating our allowances. We compute a historical payment analysis of accounts fully closed, by category. Provisions for contractual discounts and estimated uncompensated care for our Air Medical segment (expressed as a percentage of gross segment billings) were as follows:
These percentages are affected by various factors, including rate increases and changes in the number of transports by payor mix. Net reimbursement per transport from commercial payors generally increases when a rate increase is implemented. Net reimbursement from certain commercial payors, as well as Medicare and Medicaid, generally does not increase proportionately with rate increases. Net revenue attributable to Insurance, Medicare, Medicaid, and Self-Pay (expressed as a percentage of net Air Medical revenues) were as follows:
We also have a limited number of contracts with hospitals under which we receive a fixed fee component for aircraft availability and a variable fee component for flight time. Most of our contracts with hospitals contain provisions permitting early termination by the hospital, typically with 180 days’ notice for any reason and generally with penalty. Those contracts generated approximately 18% and 29% of the segment’s revenues for the quarters ended June 30, 2017 and 2016, respectively. For the six months ended June 30, 2017 and 2016, these contracts generated approximately 30% of the segment's revenues. Technical Services Segment - Our Technical Services segment provides helicopter repair and overhaul services for flight operations customers that own their aircraft. Costs associated with these services are primarily labor, and customers are generally billed at a percentage above our service costs. We also periodically provide flight services to governmental customers under this segment, including our agreement to operate six aircraft for the National Science Foundation in Antarctica, typically in the first and fourth quarters each year. Also included in this segment is our proprietary Helipass operations, which provides software as a service to certain of our Oil and Gas customers for the purpose of passenger check-in and compliance verification. For the quarters ended June 30, 2017 and 2016, approximately 3% and 5%, respectively, of our total operating revenues were generated by our Technical Services segment. For the six month period ended June 30, 2017 and 2016, approximately 4%, respectively, of our total operating revenues were generated by our Technical Services segment. Summarized financial information concerning our reportable operating segments for the quarters and six months ended June 30, 2017 and 2016 is as follows:
|
Investment in Variable Interest Entity and Other Investments and Affiliates |
6 Months Ended |
---|---|
Jun. 30, 2017 | |
Investment in Variable Interest Entity and Other Investments and Affiliates [Abstract] | |
Investment in Variable Interest Entity and Other Investments and Affiliates | INVESTMENT IN VARIABLE INTEREST ENTITY AND OTHER INVESTMENTS AND AFFILIATES PHI Century Limited - We account for our investment in our West African operations as a variable interest entity, which is defined as an entity that either (a) has insufficient equity to permit the entity to finance its operations without additional subordinated financial support or (b) has equity investors who lack the characteristics of a controlling financial interest. As of June 30, 2017, we had a 49% investment in the common stock of PHI Century Limited (“PHIC”), a Ghanaian entity. We acquired our 49% interest on May 26, 2011, PHIC’s date of incorporation. The purpose of PHIC is to provide oil and gas flight services in Ghana and the West African region. For the quarter ended June 30, 2017, we recorded income in equity of this unconsolidated affiliate of $0.1 million relative to our 49% equity ownership. For the six months ended June 30, 2017 and 2016, we recorded a loss in equity of this unconsolidated affiliate of $0.9 million and $0.1 million relative to our 49% equity ownership, respectively. We had $2.4 million and $2.0 million of trade receivables as of June 30, 2017 and December 31, 2016, respectively, from PHIC. Our investment in the common stock of PHIC is included in Other assets on our Condensed Consolidated Balance Sheets and was $0.4 million and $0.2 million at June 30, 2017 and December 31, 2016, respectively. PHI-HNZ Australia Ltd - In the fourth quarter of 2016, the Company and HNZ Group, Inc. (HHNZ) jointly formed PHI-HNZ Australia Pty Ltd., a legal entity held 50% by PHI, Inc. and 50% by HNZ Group, Inc. (“HNZ”), to provide helicopter transportation services in support of a gas development project offshore of western Australia. PHI-HNZ Australia Pty, Ltd began operations in April, 2017. For the quarter and six months ended June 30, 2017, we recorded a loss in equity of unconsolidated affiliate of $1.1 million, primarily related to startup costs associated with the contract. |
Other Comprehensive Income |
6 Months Ended |
---|---|
Jun. 30, 2017 | |
Equity [Abstract] | |
Other Comprehensive Income | OTHER COMPREHENSIVE INCOME Amounts reclassified from Accumulated other comprehensive income are not material and, therefore, not presented separately in the Condensed Consolidated Statements of Comprehensive Income. |
Condensed Consolidating Financial Information |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Condensed Consolidating Financial Information | CONDENSED CONSOLIDATING FINANCIAL INFORMATION As discussed further in Note 5, on March 17, 2014, PHI, Inc. issued $500.0 million aggregate principal amount of 5.25% Senior Notes due 2019 that are fully and unconditionally guaranteed on a joint and several, senior basis by all of PHI, Inc.’s domestic subsidiaries. PHI, Inc. directly or indirectly owns 100% of all of its domestic subsidiaries. The supplemental condensed financial information on the following pages sets forth, on a consolidated basis, the balance sheet, statement of operations, statement of comprehensive income, and statement of cash flows information for PHI, Inc. (“Parent Company”) the guarantor subsidiaries and the non-guarantor subsidiaries, each under separate headings (except for periods ending on or before December 31, 2016, in which case such information for the guarantor and non-guarantor subsidiaries is presented together). The eliminating entries eliminate investments in subsidiaries, intercompany balances, and intercompany revenues and expenses. The condensed consolidating financial statements have been prepared on the same basis as the consolidated financial statements of PHI, Inc. The equity method is followed by the Parent Company within the financial information presented below. The transactions reflected in “Due to/from affiliates, net” in the following condensed consolidated statements of cash flows primarily consist of centralized cash management activities between PHI, Inc. and its subsidiaries, pursuant to which cash earned by the guarantor subsidiaries is regularly transferred to PHI, Inc. to be centrally managed. Because these balances are treated as short-term borrowings of the Parent Company, serve as a financing and cash management tool to meet our short-term operating needs, turn over quickly and are payable to the guarantor subsidiaries on demand, we present borrowings and repayments with our affiliates on a net basis within the condensed consolidating statement of cash flows. Net receivables from our affiliates are considered advances and net payables to our affiliates are considered borrowings, and both changes are presented as financing activities in the following condensed consolidating statements of cash flows. Due to the growth of our international affiliates in Trinidad and Australia which no longer qualify as minor subsidiaries under regulation S-X 210.3-10(h)6, we have begun reporting all of our non-guarantors subs in a separate column beginning with the quarter ended June 30, 2017. PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING BALANCE SHEETS (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING BALANCE SHEETS (Thousands of dollars)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS (Thousands of dollars)
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS (Thousands of dollars)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Thousands of dollars)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Thousands of dollars)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS (Thousands of dollars)
|
Basis of Presentation (Policies) |
6 Months Ended |
---|---|
Jun. 30, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Recently Adopted Accounting Pronouncements | Recently Adopted Accounting Pronouncements - Effective January 1, 2017, we adopted Accounting Standards Update (“ASU”) 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which was issued by the Financial Accounting Standards Board (“FASB”) in March 2016. This new standard requires that excess tax benefits and deficiencies resulting from stock-based compensation awards vesting and exercises be recognized in the income statement. Previously, these amounts were recognized in additional paid-in capital. As a result, during the first quarter of 2017 we recorded a cumulative-effect adjustment of $1.0 million increasing retained earnings and decreasing deferred tax liability on our balance sheet dated June 30, 2017. Accordingly, we recorded income tax expense of $1.5 million in our consolidated statement of income for the six months ended June 30, 2017, in recognition of excess tax deficiencies related to equity compensation. Under this new standard, the corresponding cash flows are now reflected in cash provided by operating activities instead of financing activities, as was previously required. ASU 2016-09 also allows an employer with a statutory income tax withholding obligation to withhold shares with a fair value up to the amount of tax owed using the maximum statutory tax rate in the employee’s applicable jurisdiction. We have elected to continue to withhold the minimum statutory withholding obligation for outstanding awards. We have also elected to continue to estimate equity award forfeitures expected to occur to determine the amount of compensation cost to be recognized in each period. New Accounting Pronouncements - In May 2014, the FASB issued Accounting Standards Update ASU 2014-09, Revenue from Contracts with Customers, which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. Entities can transition to the standard either retrospectively or as a cumulative effect adjustment as of the date of adoption. The new standard is effective for the Company beginning on January 1, 2018. Revenues from our Oil and Gas segment and Air Medical segment hospital contracts are primarily comprised of a fixed monthly fee for a particular model of aircraft, plus a variable component based on flight time. Under the independent provider programs of our Air Medical segment, our revenues are based on a flat rate plus a variable charge per patient-loaded mile, and are recorded net of contractual allowances. We also generate revenue on a cost-plus basis in our Technical Services segment. Based on our initial assessment, the Company does not expect the adoption of this ASU to have a material impact on its condensed consolidated financial statements. Remaining implementation matters include establishing new policies, procedures, and controls and quantifying any adoption date adjustments. The Company will adopt this standard on January 1, 2018 utilizing the modified retrospective method. In February 2016, the FASB issued ASU 2016-02, Leases, which replaces the existing guidance on leasing transactions in ASC 840 to require recognition of the assets and liabilities for the rights and obligations created by those leases on the balance sheet. We are currently evaluating the effects of this standard, and expect the adoption of this standard will result in a material change to our consolidated assets and liabilities based on our lease portfolio as of June 30, 2017. We plan to adopt this standard no later than January 1, 2019. In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory, which will require an entity to recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for annual periods beginning after December 15, 2017, including interim periods within those annual periods. The effects of this standard on our financial position, results of operations, and cash flows are not yet known. We plan to adopt this standard beginning January 1, 2018. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. ASU 2017-01 clarifies the definition of a business and requires that an entity apply certain criteria in order to determine when a set of assets and activities qualifies as a business. The adoption of this standard is expected to result in fewer acquisitions of properties qualifying as acquisitions of businesses and, accordingly, acquisition costs for those acquisitions that do not qualify as businesses will be capitalized rather than expensed. This standard is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years, and should be applied on a prospective basis. Early adoption is permitted. The effects of this standard on our financial position, results of operations, and cash flows are not yet known. We plan to adopt this standard beginning January 1, 2018. In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 simplifies the current two-step goodwill impairment test by eliminating the second step of the test. The new standard requires a one-step impairment test in which an entity compares the fair value of a reporting unit with its carrying amount and recognizes an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, if any. This standard is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and should be applied on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. We do not expect this ASU to have a material impact on our consolidated financial statements. |
Investments (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of Investments | Investments consisted of the following as of June 30, 2017:
Investments consisted of the following as of December 31, 2016:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cost and Fair Value of Debt Investments Based on Maturities | The following table presents the cost and fair value of our debt investments based on maturities as of:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Coupon Rate Percentage and Average Days to Maturity of Debt | The following table presents the average coupon rate percentage and the average days to maturity of our debt investments as of:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments in Continuous Unrealized Loss Position for Less Than Twelve Months | The following table presents the fair value and unrealized losses related to our investments that have been in a continuous unrealized loss position for less than twelve months as of:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments in Continuous Unrealized Loss Position for More Than Twelve Months | The following table presents the fair value and unrealized losses related to our investments that have been in a continuous unrealized loss position for more than twelve months as of:
|
Revenue Recognition and Valuation Accounts (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | ||||||||||||||||||||||||||||||||||||
Revenue Recognition And Valuation Accounts [Abstract] | ||||||||||||||||||||||||||||||||||||
Schedule of Allowance for Contractual Discounts and Estimated Uncompensated Care as a Percentage of Gross Segment Accounts Receivable | The allowance for contractual discounts and estimated uncompensated care (expressed as a percentage of gross segment accounts receivable) as of the dates listed below was as follows:
|
Fair Value Measurements (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Valuation of Investments and Financial Instruments Pricing Levels | The following table summarizes the valuation of our investments and financial instruments by the above pricing levels as of the valuation dates listed:
|
Long Term Debt (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of Long-term Debt | The components of long-term debt as of the dates indicated below were as follows:
|
Earnings Per Share (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of Basic and Diluted Earnings Per Share | The components of basic and diluted earnings per share for the quarter and six months ended June 30, 2017 and 2016 are as follows:
|
Stock-Based Compensation (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Share Based Compensation Expense | The table below sets forth the total amount of stock-based compensation expense for the six months and quarter ended June 30, 2017 and 2016.
|
Segment Information (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Provisions for Contractual Discounts and Estimated Uncompensated Care as a Percentage of Gross Segment Billings | Provisions for contractual discounts and estimated uncompensated care for our Air Medical segment (expressed as a percentage of gross segment billings) were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Revenue Attributable to Insurance, Medicare, Medicaid, and Self-Pay as Percentage of Net Air Medical Revenues |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Financial Information Concerning Reportable Operating Segments | Summarized financial information concerning our reportable operating segments for the quarters and six months ended June 30, 2017 and 2016 is as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Depreciation and Amortization Expense Included in Direct Expenses and Unallocated Selling, General, and Administrative Costs |
|
Condensed Consolidating Financial Information (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Condensed Consolidating Balance Sheets | PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING BALANCE SHEETS (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING BALANCE SHEETS (Thousands of dollars)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Condensed Consolidating Statements of Operations | PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS (Thousands of dollars)
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS (Thousands of dollars)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Condensed Consolidated Statements of Comprehensive Income (Loss) | PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Thousands of dollars)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Thousands of dollars)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Condensed Consolidating Statements of Cash Flows | PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS (Thousands of dollars) (Unaudited)
PHI, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS (Thousands of dollars)
|
Basis of Presentation - Additional Information (Detail) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
Mar. 31, 2017 |
|
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||
Income tax expense | $ 123 | $ (4,160) | $ (7,702) | $ (2,716) | |
Accounting Standards Update 2016-09 [Member] | |||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||
Deferred tax liability | $ 1,000 | ||||
Income tax expense | $ 1,500 | ||||
Retained Earnings [Member] | Accounting Standards Update 2016-09 [Member] | |||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||
Cumulative effect adjustment | $ 1,000 |
Investments - Additional Information (Detail) - USD ($) $ in Thousands |
Jun. 30, 2017 |
Dec. 31, 2016 |
---|---|---|
Investments, Debt and Equity Securities [Abstract] | ||
Restricted cash and investments | $ 12,396 | $ 13,038 |
Investments - Cost and Fair Value of Debt Investments Based on Maturities (Detail) - USD ($) $ in Thousands |
Jun. 30, 2017 |
Dec. 31, 2016 |
---|---|---|
Available-for-sale Securities, Debt Maturities [Abstract] | ||
Due in one year or less, Amortized Costs | $ 175,910 | $ 184,587 |
Due within two years, Amortized Costs | 56,171 | 100,816 |
Total, Amortized Costs | 232,081 | 285,403 |
Due in one year or less, Fair Value | 175,682 | 184,334 |
Due within two years, Fair Value | 56,053 | 100,378 |
Total, Fair Value | $ 231,735 | $ 284,712 |
Investments - Average Coupon Rate Percentage and the Average Days to Maturity of Debt (Detail) |
6 Months Ended | 12 Months Ended |
---|---|---|
Jun. 30, 2017 |
Dec. 31, 2016 |
|
Commercial Paper [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Average Coupon Rate | 98.50% | 100.10% |
Average Days To Maturity | 83 days | 184 days |
US Government Agencies [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Average Coupon Rate | 105.60% | 97.00% |
Average Days To Maturity | 264 days | 400 days |
Corporate Bonds and Notes [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Average Coupon Rate | 172.00% | 174.50% |
Average Days To Maturity | 246 days | 318 days |
Investments - Investments in Continuous Unrealized Loss Position for Less Than Twelve Months (Detail) - USD ($) $ in Thousands |
Jun. 30, 2017 |
Dec. 31, 2016 |
---|---|---|
Schedule of Available-for-sale Securities [Line Items] | ||
Fair Value | $ 202,464 | $ 251,966 |
Unrealized Losses | (311) | (673) |
Commercial Paper [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Fair Value | 16,998 | 27,867 |
Unrealized Losses | (10) | (39) |
US Government Agencies [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Fair Value | 13,287 | 13,263 |
Unrealized Losses | (15) | (32) |
Corporate Bonds and Notes [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Fair Value | 172,179 | 210,836 |
Unrealized Losses | $ (286) | $ (602) |
Investments - Investments in Continuous Unrealized Loss Position for More Than Twelve Months (Detail) - USD ($) $ in Thousands |
6 Months Ended | 12 Months Ended |
---|---|---|
Jun. 30, 2017 |
Dec. 31, 2016 |
|
Schedule of Available-for-sale Securities [Line Items] | ||
Fair Value | $ 21,060 | $ 24,196 |
Unrealized Losses | (36) | (20) |
US Government Agencies [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Fair Value | 1,996 | 0 |
Unrealized Losses | (4) | 0 |
Corporate Bonds and Notes [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Fair Value | 19,064 | 24,196 |
Unrealized Losses | $ (32) | $ (20) |
Revenue Recognition and Valuation Accounts - Additional Information (Detail) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
Dec. 31, 2016 |
|
Valuation and Qualifying Accounts Disclosure [Line Items] | |||||
Allowance for doubtful accounts | $ 6.0 | $ 6.0 | $ 6.0 | ||
Value of services to patients who are unable to pay | 2.0 | $ 2.2 | 4.4 | $ 4.7 | |
Estimated cost of providing charity services | 0.4 | $ 0.5 | 1.0 | $ 1.2 | |
Valuation reserves related to obsolescence and slow moving inventory | 17.7 | 17.7 | 17.3 | ||
Air Medical [Member] | |||||
Valuation and Qualifying Accounts Disclosure [Line Items] | |||||
Allowance for contractual discounts against outstanding accounts receivable | 110.9 | 110.9 | 111.9 | ||
Allowance for uncompensated care against outstanding accounts receivable | $ 46.2 | $ 46.2 | $ 46.3 |
Revenue Recognition and Valuation Accounts - Schedule of Allowance for Contractual Discounts and Estimated Uncompensated Care as a Percentage of Gross Segment Accounts Receivable (Detail) - Air Medical [Member] - Trade Accounts Receivable [Member] |
Jun. 30, 2017 |
Dec. 31, 2016 |
---|---|---|
Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Allowance for Contractual Discounts | 56.00% | 56.00% |
Allowance for Uncompensated Care | 23.00% | 23.00% |
Fair Value Measurements - Additional Information (Detail) - USD ($) |
Jun. 30, 2017 |
Dec. 31, 2016 |
Mar. 17, 2014 |
---|---|---|---|
Fair Value Measurements Disclosure [Line Items] | |||
The fair value investments reclassification of assets between level 1 and level 2 | $ 0 | $ 0 | |
The fair value of Senior Notes, based on quoted market prices | 463,000,000 | 474,400,000 | |
Fair Value, Inputs, Level 3 [Member] | |||
Fair Value Measurements Disclosure [Line Items] | |||
Level 3 investments | $ 0 | $ 0 | |
5.25% Senior Notes due March 15, 2019 [Member] | Senior Notes [Member] | |||
Fair Value Measurements Disclosure [Line Items] | |||
Interest rate on Senior Notes | 5.25% | 5.25% |
Long Term Debt - Components of Long-term Debt (Detail) - USD ($) $ in Thousands |
Jun. 30, 2017 |
Dec. 31, 2016 |
---|---|---|
Debt Instrument [Line Items] | ||
Principal | $ 633,225 | $ 634,000 |
Unamortized debt issuance debt costs | 2,129 | 2,753 |
5.25% Senior Notes due March 15, 2019 [Member] | Senior Notes [Member] | ||
Debt Instrument [Line Items] | ||
Principal | 500,000 | 500,000 |
Unamortized debt issuance debt costs | 2,129 | 2,753 |
Revolving Credit Facility [Member] | ||
Debt Instrument [Line Items] | ||
Principal | $ 133,225 | $ 134,000 |
Long Term Debt - Components of Long-term Debt (Additional Information) - 5.25% Senior Notes due March 15, 2019 [Member] - Senior Notes [Member] |
6 Months Ended | |
---|---|---|
Jun. 30, 2017 |
Mar. 17, 2014 |
|
Debt Instrument [Line Items] | ||
Interest rate on Senior Notes | 5.25% | 5.25% |
Senior Notes payable periods | Mar. 15, 2019 |
Long Term Debt - Additional Information (Detail) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
Dec. 31, 2016 |
Mar. 17, 2014 |
|
Debt Instrument [Line Items] | ||||||
Letters of credit outstanding under the facility | $ 12,400,000 | $ 12,400,000 | $ 13,000,000 | |||
5.25% Senior Notes due March 15, 2019 [Member] | Senior Notes [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate on Senior Notes | 5.25% | 5.25% | 5.25% | |||
Maturity date of Senior notes payable | Mar. 15, 2019 | |||||
Debt instrument interest rate term | Interest is payable semi-annually on March 15 and September 15 of each year. | |||||
Debt instrument redemption date | On or after March 15, 2016 | |||||
Percentage of principal amount redeemed | 101.00% | |||||
Debt instrument restrictive covenants | The indenture governing the 2019 Notes (the “2019 Indenture”) contains, among other things, certain restrictive covenants, including limitations on incurring indebtedness, creating liens, selling assets and entering into certain transactions with affiliates. The covenants also limit PHI’s ability to, among other things, pay cash dividends on common stock, repurchase or redeem common or preferred equity, prepay subordinated debt and make certain investments. | |||||
Interest Expense Fund [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Periodic payment of debt interest | $ 1,200,000 | $ 600,000 | $ 15,300,000 | $ 14,300,000 | ||
Revolving Credit Facility [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Revolving credit facility, maturity date | Oct. 01, 2018 | |||||
Increased Borrowing capacity | $ 150,000,000 | $ 150,000,000 | ||||
Revolving Credit facility, Covenants, consolidated working capital ratio | 200.00% | 200.00% | ||||
Revolving Credit facility, Covenants, consolidated net worth ratio | 150.00% | 150.00% | ||||
Revolving Credit facility, Covenants, fixed coverage ratio | 110.00% | 110.00% | ||||
Revolving Credit facility, Covenants, consolidated net worth | $ 450,000,000 | $ 450,000,000 | ||||
Letters of credit outstanding under the facility | $ 7,600,000 | $ 7,600,000 | ||||
Revolving Credit Facility [Member] | LIBOR [Member] | ||||||
Debt Instrument [Line Items] | ||||||
LIBOR plus interest rate on borrowed funds | 2.25% |
Earnings Per Share - Components of Basic and Diluted Earnings Per Share (Detail) - shares shares in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
Weighted Average Number of Shares Outstanding Reconciliation [Abstract] | ||||
Weighted average outstanding shares of common stock, basic | 15,716 | 15,677 | 15,716 | 15,650 |
Dilutive effect of unvested restricted stock units | 0 | 41 | 0 | 0 |
Weighted average outstanding shares of common stock, diluted | 15,716 | 15,718 | 15,716 | 15,650 |
Earnings Per Share - Components of Basic and Diluted Earnings Per Share (Additional Information) (Detail) - shares |
6 Months Ended | |
---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
|
Weighted Average Number of Shares Outstanding Reconciliation [Abstract] | ||
Anti-dilutive securities | 438,812 | 3,180 |
Stock-Based Compensation - Summary of Share Based Compensation Expense (Detail) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
Stock-based compensation expense: | ||||
Total stock-based compensation expense | $ 1,261 | $ 1,406 | $ 1,816 | $ 2,896 |
Time-based Restricted Units [Member] | ||||
Stock-based compensation expense: | ||||
Total stock-based compensation expense | 556 | 597 | 1,111 | 1,216 |
Performance-based Restricted Units [Member] | ||||
Stock-based compensation expense: | ||||
Total stock-based compensation expense | $ 705 | $ 809 | $ 705 | $ 1,680 |
Stock-Based Compensation - Additional Information (Detail) - shares |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
Time-based Restricted Units [Member] | ||||
Stock Based Compensation [Line Items] | ||||
Restricted units awarded to managers (shares) | 417,266 | 14,288 | 447,477 | 14,288,000 |
Performance-based Restricted Units [Member] | ||||
Stock Based Compensation [Line Items] | ||||
Restricted units awarded to managers (shares) | 365,539 | 5,102 | 365,539,000 | 308,163 |
Asset Disposals - Additional Information (Detail) $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Jun. 30, 2017
Aircraft
|
Mar. 31, 2017
Aircraft
|
Jun. 30, 2016
USD ($)
Aircraft
|
Mar. 31, 2016
USD ($)
Aircraft
|
|
Assets Held For Sale And Impairments [Line Items] | ||||
Number of aircraft sold | 0 | |||
Cash realized from sale of assets | $ | $ 10.1 | $ 0.9 | ||
Gain (loss) on disposal of assets | $ | $ 4.3 | $ 0.4 | ||
Oil and Gas [Member] | Light Aircraft [Member] | ||||
Assets Held For Sale And Impairments [Line Items] | ||||
Number of aircraft sold | 4 | 1 | ||
Oil and Gas [Member] | Medium Aircraft [Member] | ||||
Assets Held For Sale And Impairments [Line Items] | ||||
Number of aircraft sold | 5 | 3 |
Segment Information - Schedule of Provisions for Contractual Discounts and Estimated Uncompensated Care as a Percentage of Gross Segment Billings (Detail) - Air Medical [Member] |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
Provisions For Contractual Discounts And Estimated Uncompensated Care [Line Items] | ||||
Provision for contractual discounts | 63.00% | 65.00% | 66.00% | 69.00% |
Provision for uncompensated care | 10.00% | 7.00% | 7.00% | 4.00% |
Segment Information - Schedule of Net Revenue Attributable to Insurance, Medicare, Medicaid, and Self-Pay as Percentage of Net Air Medical Revenues (Detail) - Air Medical [Member] |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
Insurance [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Percentage of net Air Medical revenues | 72.00% | 69.00% | 71.00% | 70.00% |
Medicare [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Percentage of net Air Medical revenues | 18.00% | 18.00% | 18.00% | 18.00% |
Medicaid [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Percentage of net Air Medical revenues | 8.00% | 9.00% | 9.00% | 10.00% |
Self Pay [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Percentage of net Air Medical revenues | 2.00% | 4.00% | 2.00% | 2.00% |
Investment in Variable Interest Entity and Other Investments and Affiliates - Additional Information (Detail) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2017 |
Dec. 31, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
PHI Century Limited [Member] | ||||
Variable Interest Entity [Line Items] | ||||
Investment in the common stock | 49.00% | 49.00% | 49.00% | |
Earnings (loss) in equity of unconsolidated affiliate | $ 0.1 | $ (0.9) | $ 0.1 | |
Trade receivables | 2.4 | $ 2.0 | 2.4 | |
Other assets | 0.4 | $ 0.2 | $ 0.4 | |
PHIC's date of incorporation | May 26, 2011 | |||
PHI-HNZ Australia Ltd [Member] | ||||
Variable Interest Entity [Line Items] | ||||
Investment in the common stock | 50.00% | |||
Earnings (loss) in equity of unconsolidated affiliate | $ 1.1 | $ 1.1 | ||
HNZ Group, Inc. [Member] | PHI-HNZ Australia Ltd [Member] | ||||
Variable Interest Entity [Line Items] | ||||
Investment in the common stock | 50.00% |
Condensed Consolidating Financial Information - Additional Information (Detail) - USD ($) |
Jun. 30, 2017 |
Mar. 17, 2014 |
---|---|---|
Supplemental Guarantor Financial Information [Line Items] | ||
Ownership percentage in domestic subsidiaries | 100.00% | |
5.25% Senior Notes due March 15, 2019 [Member] | Senior Notes [Member] | ||
Supplemental Guarantor Financial Information [Line Items] | ||
Senior notes, amount issued | $ 500,000,000 | |
Interest rate on Senior Notes | 5.25% | 5.25% |
^M032Q>BN+OXRET/(>)_P);!R03(/D$
M8&.AJ/P+=[S(# [$C+/O>+CB[3[QLRE#,(XB_O/BK8^>BVUZD[%S()IR#F-.
MLLR9,YAGGTLD:R4.R3_P9!V^6U6XB_#=7PIOUPG258(T$J3_;7$MY^Y3$;:8
MJ0+3Q&VRI,1>QTU>1.>%O4_BG?Q)'[?].S>-T): @]P2G8B&"8_]SD$14Y
M(@3A1@3#['&1&!6)$8+#1@3#1+A(@HHD",%Q(X)AXHT(6?WG'&3M.EQYA1@Z
M-UU6WF6(/(:N3_["IPGTE Y@C;">%=E)@QW%_,Y@@6UZO.4R0
M+ZC7'$Q(2$EH34+F3Z-6@HSRCR#8TUTG(F3@JAS#J"+$N<:3 >*)H>?T2A@LANM@5
M3'-R4!:FN3TO2$:4.0QAQ- 2QM"<'M 0DKD-8<@0HHSCK4@8,_0.SA TA
M# T))Z6>R0UFT*>J$"N^4"[4QU1\(3BR9V YO<$&<_S!GDSNM*!
M'MOBAN.*&& ?G!=D/O[(G]&>#A0]')GQ160"34S,5_@0LH# ]*,$=IE(LK*0?G
MC9Y94(H6+],NN[B/TTUZA6T#^ S@"^ N MB4*"K_(+PH,FM&8J?>]R(\<7+@
MV)LR.&,KXAV*=^B]%,EMDK%+()ICCE,,7\
MA"?>';GO31F
TPQXQP'2<73"
M=0'O#H [-./= =$MFB/7D?OG/%$,[R- ^HA&$RGP[H#D#LEX=P#V?;8D+P'Y
M\EY]LP'O(T#ZB-J?1D#ZR*H27"Q-*RYW9A7?>&MQK,T6XF)VV"D\=4O;__!N
MF_&=R5U1-]ZK4'J!;):Q6R$4UTS"!\UAKW